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ABSTRACT 
 
Provitamin A carotenoids, tocopherols, and phylloquinone, as the major fat-soluble 
micronutrients in salad vegetables, play essential roles in maintaining various physiological 
processes, such as cell differentiation and proliferation, normal organogenesis, and blood 
clotting.  The non-provitamin A carotenoids, particularly lutein, zeaxanthin, and lycopene are 
important for maintaining ocular health and preventing chronic diseases.  The intestinal 
uptake of fat-soluble micronutrients involves both simple diffusion and receptor-mediated 
transport.  Various exogenous factors are able to affect the uptake process, e.g. food matrix 
and processing, dietary fat and fiber, and nutrient species and stereoisomers.  Transferring 
fat-soluble micronutrients into the blood circulation depends on the normal synthesis of 
apolipoproteinB (apoB) and apoB-containing lipoprotein, which is promoted by the presence 
of sufficient lipids and suppressed by insulin.  Overall, dietary fat is an elementary factor 
regulating the absorption of fat-soluble micronutrients. 
Lecithin may influence the bioavailability of fat-soluble micronutrients.  The role of 
the large very-low-density lipoprotein (VLDLA) plasma fraction in postprandial fat-soluble 
micronutrient transport is not clearly defined.  Therefore, we conducted a human study to 
investigate the effects of the lecithin/oil ratio in salad dressing on the absorption of: 1) 
carotenoids, phylloquinone, and tocopherols from salad vegetables; 2) retinyl palmitate 
formed in the intestine from the provitamin A carotenoids.  An additional objective was to 
investigate the origin of plasma chylomicrons and VLDLA and their roles in the transport of 
the absorbed fat-soluble micronutrients.  Healthy women (n = 12) each consumed three 
salads with salad dressings containing: 1) 4 g soybean oil and 0 g hydroxylated soy lecithin 
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(Solec® 8120, Solae, St. Louis, MO); 2) 3.8 g soybean oil and 0.2 g Solec® 8120; or 3) 3.2 g 
of soybean oil and 0.8 g Solec® 8120.  The order in which the salads were consumed was 
randomly assigned according to a Williams Latin square design; salads were separated by ≥ 2 
weeks.  Blood was collected at baseline and 2, 3.5, 5, 7, and 9.5 h postprandially.  
Chylomicrons and VLDLA fractions were analyzed by HPLC with coulometric array 
electrochemical detection.  ApoB-48 and apoB-100 contents in chylomicrons and VLDLA 
were determined by ELISA.  There were no significant differences among the salad dressings 
in the resulting AUC values of the fat-soluble micronutrients in the chylomicron and VLDLA 
fractions.  The exception was a decrease in the AUC value of phylloquinone in the 
chylomicron fraction when the salad dressing containing 0.8 g was compared with that 
containing 0 g Solec® 8120 (P < 0.02).  The AUC values for α-carotene, β-carotene, 
lycopene, retinyl palmitate, and phylloquinone were substantially higher in the VLDLA than 
in the chylomicron fraction (P < 0.05).  Both chylomicron and VLDLA fractions contained 
apoB-48 and apoB-100.  ApoB-48 and apoB-100 were predominantly found in the VLDLA 
fraction (P < 0.0001).  The AUC value of apoB-100 in VLDLA was significantly higher than 
that of apoB-48 in chylomicrons (P < 0.0001).  We concluded that the hydroxylated soy 
lecithin in the amounts added to the salad dressing did not enhance the absorption of 
carotenoids, retinyl palmitate, phylloquinone, or tocopherols.  The majority of the newly 
absorbed carotenoids, retinyl palmitate, and phylloquinone, as well as enterogenous (apoB-
48) and hepatogenous (apoB-100) lipoprotein particles, were contained within large VLDL.  
Thus this lipoprotein subfraction has a major role in the transport of newly absorbed 
carotenoids and fat-soluble vitamins.   
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CHAPTER I.  
GENERAL INTRODUCTION 
 
Salad consumption, as a major contributor to vegetable consumption in the United States, 
is associated with a greater likelihood of meeting the recommended intakes for various nutrients, 
including carotenoids and vitamin E (Su & Arab, 2006).  Although it has been reported that the 
bioavailability of nutrients, including provitamin A carotenoids, is low in raw vegetables (Rock 
et al., 1998), the absorption of fat-soluble micronutrients from vegetables is able to be improved 
by increasing the fat content of a meal (Dimitrov et al., 1988; Gijsbers et al., 1996).  We 
previously reported that carotenoid absorption was higher after the consumption of salads with 
full-fat than with reduced-fat salad dressing, whereas no absorption of carotenoids was observed 
when salads were consumed with fat-free salad dressing (Brown et al., 2004).  The consumption 
of 150 g avocado or 24 g avocado oil with vegetable salads resulted in similarly enhanced α-
carotene, β-carotene, and lutein absorption compared with the consumption of avocado/avocado 
oil-free salads (Unlu et al., 2005).  More recently, we found that the absorption of carotenoids, 
tocopherols, and phylloquinone increased linearly with increasing amounts of co-consumed fat 
from salad dressings (Agustiana et al., 2010).  However, it is not recommended to have 
excessively high fat intakes to achieve high bioavailability of fat-soluble micronutrients.  To 
further enhance the absorption efficiency, one strategy is to find a lipid that is more efficient than 
triacylglycerol in increasing the bioavailability of fat-soluble micronutrients.  
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The intestinal absorption of fat-soluble micronutrients involves the release from food 
matrix, emulsification with lipid droplets in the stomach, and incorporation into mixed micelles 
(Yonekura et al., 2007).  Lecithin, as a structural component of mixed micelles and an excellent 
emulsifier, is likely to enhance the absorption of dietary lipids and lipophilic nutrients.  Soybean 
lecithin was to reported to increase the lymphatic absorption of triglyceride in rats (Nishimukai 
et al., 2003).  Higher concentration of curcumin, a hydrophobic constituent of the spice turmeric, 
was observed in rat plasma and liver when curcumin was formulated with soybean lecithin 
compared with unformulated curcumin (Marczylo et al., 2007).  However, few human studies 
have addressed the effects of the dietary lecithin on the bioavailability of fat-soluble 
micronutrients. 
The utility of postprandial appearance of β-carotene and retinyl palmitate in 
chylomicrons and large very low density lipoproteins (VLDLA) as an indicator of intestinal β-
carotene absorption have been studied well in humans (Hu et al., 2000; Paetau et al., 1997; Li et 
al., 2010).  In our previous studies, after subjects consumed a β-carotene dose with a fat-rich 
meal, we observed postprandial appearances of β-carotene and retinyl palmitate in the plasma 
chylomicron fraction coincided in time and magnitude with their appearance in VLDLA (Hu et 
al., 2000; Paetau et al., 1997).  Although it is known that the VLDLA fraction is a vehicle for 
assessing intestinal absorption of β-carotene and its major bioconversion product, retinyl 
palmitate (Hu et al., 2000; Paetau et al., 1997; Borel et al., 1997; Li et al., 2010), there has been 
little systematic study of the role of VLDLA in the transport of other newly absorbed fat-soluble 
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micronutrients, such as α-carotene, lycopene, lutein, tocopherols, and phylloquinone.  The 
postprandial appearance of retinyl palmitate in VLDLA was hypothesized to be attributed to 
intestinal VLDL (Borel et al., 1997), but could also reflect their appearance in chylomicron 
remnants (Zheng et al., 2006).  However, VLDLA have long been regarded as liver-derived 
lipoproteins (Karpe et al., 1994; Brodsky et al., 2008).  Apolipoprotein B-48 (apoB-48) and 
apolipoprotein B-100 (apoB-100) are reliable biomarkers of lipoprotein particles of intestinal and 
hepatic origin, respectively (Lemieus et al., 1998; Phillips et al., 1997; Chan J, 1992).  Therefore, 
an investigation of apoB-48 and apoB-100 in the plasma VLDLA fraction after a single meal can 
provide new insight regarding the origin of VLDLA.  
The objectives of the present study were to investigate the effects of the lecithin/oil ratio 
in salad dressing on the absorption of carotenoids, phylloquinone, and tocopherols from salad 
vegetables and and retinyl palmitate from intestinal metabolism of the provitamin A carotenoids.  
An additional objective was to investigate the origin of VLDLA and the roles of plasma 
chylomicrons and VLDLA in the transport of the absorbed fat-soluble micronutrients. 
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CHAPTER II.  
LITERATURE REVIEW 
 
Physiological Functions of Carotenoids, Phylloquinone and Tocopherols 
 
Carotenoids  
Carotenoids are hydrophobic pigments synthesized by photosynthetic organisms.  They 
provide plants with deep yellow, orange and red colors.  Other non-photosynthesizing organisms 
only can obtain carotenoids by dietary intake.  Carotenoid accumulations in tissues can pigment 
animals such as birds and fish.  Carotenoids can be divided into two categories: provitamin A 
carotenoids and non-provitamin A, according to whether they can be converted into provitamin 
A (von Lintig et al., 2010).   
The provitamin A carotenoids include α-carotene, β-carotene and β-cryptoxanthin.  β-
Carotene can be catalyzed by β-carotene 15,15'-monooxygenase 1 (BCMO 1) to from two retinal 
molecules (von Lintig et al., 2010), whereas α-carotene and β-cryptoxanthin are only able to 
generate a single retinal molecule because they contain one non-hydroxylated β-ring (Davis et 
al., 2008).  The retinal is subsequently reduced to retinol (vitamin A) by retinal reductase, and a 
minor proportion of the retinal is irreversibly oxidized to retinoic acids by retinal 
dehydrogenases.  Sufficient vitamin A and its derivatives (retinal and retinoic acid) are 
indispensible for normal immune system, cell differentiation, normal organogenesis, and eye 
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health (Sommer et al., 2012).  Vitamin A deficiency, which is a widespread health problem in the 
developing world, causes more than a million cases of death and blindness every year (Sommer 
et al., 2012, Sommer et al., 1981).  Increasing studies indicated that high consumption of 
carotenoid-rich fruits and vegetables was linked with a decreased occurrence of cancers 
(Thomson et al., 2013; Reiss et al., 2012; Takata et al., 2013; Jung et al., 2013).  It had been 
hypothesized that β-carotene might prevent cancer development.  In contrast, supplementation 
trials showed that supplementation with β-carotene increased, rather than decreased, incidence of 
lung cancer in cigarette smokers (The ATBC Cancer Prevention Study Group, 1994; Albanes et 
al., 1995; Omenn et al., 1996).  However, recently, Pham et al. (2013) reported BCMO1, which 
was regulated by β-carotene uptake, had capabilities of inhibiting invasiveness of colon cancer 
cells and expressions of two neoplasia-related metalloproteinases (MMP7 and MMP28).  In 
several animal studies, α-carotene indicated higher tumorigenesis prevention capability than β-
carotene in the liver, lung, colon, and skin (Murakoshi et al., 1992, Narisawa et al., 1996).  β-
Cryptoxanthin is rich in Satsuma mandarin orange.  It has been shown that Satsuma mandarin 
juices have a chemopreventive effect on chemically induced tumorigenesis in rat colon and lung 
(Tanaka et al., 2000, Kohno et al., 2001).  Iskandar et al. (2013) recently reported that nicotine-
induced emphysema and lung tumor volume and multiplicity were reduced when mice were 
dosed with β-cryptoxanthin supplement.  Meanwhile, β-cryptoxanthin supplementation increased 
expressions of tumor suppressors including sirtuin, p53, and retinoic acid recptor (RAR)-β 
(Iskandar et al., 2013).  Besides suppressing oncogenesis, β-cryptoxanthin has been 
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demonstrated to play a vital role in preventing bone loss by regulating various gene expressions 
that are involved in osteoblastic bone formation and osteoclastic bone resorption.  The dietary 
intake of β-cryptoxanthin was associated with maintaining bone homeostasis in animal models as 
well as in menopausal women (Yamaguchi et al., 2012). 
The non-provitamin A carotenoids, particularly lutein, zeaxanthin, and lycopene are 
important for maintaining many physiological processes (Sommer et al., 2012).  Lutein and 
zeaxanthin are selectively accumulated in the primate retina and form the macular pigment.  
They are well-known xanthophylls because of their blue light filtering and antioxidant activities.  
It has been shown that lutein and zeaxanthin may play vital roles in inhibiting various ocular 
diseases, including age-related macular degeneration (AMD), photophobia, and cataracts 
(Kalariya et al., 2012).  In addition to maintaining ocular health, increasing studies suggest that 
lutein has protective effects on immune system and inflammation.  Lutein can prevent various 
ocular inflammation induced by endotoxin, laser, and streptozotocin.  In vitro studies indicate 
that lutein is able to inhibit NF kappa-B activation and iNOS (inducible nitric oxide synthase) 
and COX-2 (prostaglandin-endoperoxide synthase 2) expressions (Kijlstra et al., 2012).  
Lycopene, which is abundant in tomatoes and processed tomato products, contains 11 conjugated 
double bonds.  Therefore, as one of most powerful antioxidant, its singlet-oxygen-quenching 
ability is about two times higher than that of β-carotene and 10 times higher than that of α-
tocopherol (Di Mascio et al., 1989).  Because of the antioxidant property, lycopene was 
hypothesized to be able to prevent chronic diseases.  Recent studies show lycopene may exert 
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suppressive effects on various chronic diseases, including cancer and cardiovascular disease by 
reducing reactive oxygen species (ROS) levels (Giovannucci et al., 1999, Rao et al., 2002, 
Palozza et al., 2010a, Palozza et al., 2010b).  Various redox molecules were modulated by 
lycopene such as antioxidant response elements (ARE), ROS-producing enzymes, small-
GTPases, mitogen-activated protein kinases (MAPK), nuclear factor-κB (NF-κB), activator 
protein-1 (AP-1), as well as redox-sensitive proteins including p53, the Bcl-2 family proteins, 
and the Ku proteins (Palozza et al., 2012). 
 
Tocopherols 
Vitamin E, one of major fat-soluble antioxidants, is composed of eight compounds 
including α-, β-, γ-, and δ-tocopherols, as well as α-, β-, γ-, and δ-tocotrienols.  α- Tocopherol, as 
the most potent form of vitamin E, constitutes more than 90% of vitamin E in the human body 
(Gohil et al., 2008; Brigelius-Flohe et al., 1999; Burton et al., 1990), whereas γ-tocopherol is the 
predominant form of vitamin E in the diet (Rigotti et al., 2007).  The α-tocopherol synthesized by 
plants only have one stereoisomer, RRR, while synthetic α-tocopherol, found in supplements and 
fortified food, contains equimolar concentrations of 2R-stereoisomeric and 2S-stereoisomeric 
forms, i.e. RRR- , SRR- , RSR- , SSR- , RRS- , SRS- , RSS- , and SSS-α-tocopherol.  The 
recommended daily allowance (RDA) for vitamin E is 15 mg per day for adult males and 
females, which is supposed to maintain the plasma α-tocopherol concentration as 12 μmol/L 
(Johnson et al., 2003).  Novotny et al. (2012) recently report that 4 mg of RRR-α-tocopherol 
10 
 
 
intake can maintain the plasma RRR-α-tocopherol concentrations at 23 mmol/L, which suggest 
the actual vitamin E dietary requirement may be less than the current.  The α-tocopherol, as a a 
peroxyl radical scavenger, protects erythrocytes from oxidative damage, which prevents 
peroxide-induced hemolysis.  Therefore, hemolysis-induced anemia is a common symptom in 
patients with vitamin E deficiency (Niki et al., 2012).  Moreover, vitamin E deficiency also can 
cause muscular weakness, neurological dysfunction, and reproductive failure (Burton et al., 
1990; Kayden et al., 1993; Traber et al., 1996).   
α-Tocopherol is significantly associated with cell proliferation and apoptosis by affecting 
cell signaling and gene expression.  These activities may relate to the specific distribution of α-
tocopherol in plasma membrane, i.e., it tends to incorporate into lipid rafts and associate with 
alterations in raft-related signaling pathways.  In vascular smooth muscle cells, α-tocopherol can 
inhibit protein kinase activity by dephosphorylation (Boscoboinik et al., 1991; Ricciarelli et al., 
1998).  Although the mechanism details have not been clarified, protein phosphatase 2A has 
been shown to be involved in this process (Boudreau et al., 2002).  α-Tocopherol also can 
prevent the proliferation of vascular smooth muscle cells, which is not mainly caused by its 
antioxidant property because β-tocopherol did not exert this inhibition effect (Tasinato et al., 
1995).  Tasinato et al. (1995) repored that the antiproliferative effect was correlated with 
inhibition of protein kinase activity via gene expression alteration.  Moreover, α-tocopherol has 
been found to protect various cell types of the vacular wall from cholesterol oxide-induced 
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mitochondrial dysfunction and apoptosis (Vejux et al., 2009; Royer et al., 2009; Miguet-Alfonsi 
et al., 2002; Lizard et al., 2000).   
 
Phylloquinone 
Phylloquinone, also named vitamin K1, is the major form of vitamin K in the diet 
synthesized by plants.  Another dietary form of vitamin K is menaquinones (vitamin K2) which 
are synthesized by bacteria.  The best sources of phylloquinone are green vegetables since 
phylloquinone is correlated with photosynthetic tissues (Shearer et al., 1996).   The Adequate 
Intake (AI) for vitamin K is 120 μg/day for men and 90 μg/day for women, while no RDA has 
been established for phylloquinone (Institute of Medicine, 2001).  Phylloquinone is an essential 
cofactor of γ-carboxylase, an enzyme catalyzing the γ-carboxylation of glutamate residues in 
proteins. This vitamin K-dependent γ-carboxylation has been found to be a post-translational 
modification process and enables the proteins, referred to as vitamin K-dependent proteins, to 
bind to calcium and interact with phospholipids, which are required by blood clotting and bone 
mineralization (Shearer et al., 2009).   
Four vitamin K-dependent plasma proteins are indispensible for blood clotting.  They are 
the coagulation cascade zymogens: factor II (prothrombin), factor VII, factor IX, and factor X, 
which are all synthesized in the liver.  These coagulation cascade zymogens catalyze the 
formation of fibrin, an insoluble fiber network essentially required in blood clotting (Shearer et 
al., 2009).  On the other hand, three vitamin K-dependent plasma proteins are involved in 
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anticoagulation including protein C, protein S, and protein Z (Broze et al., 2001; Furie et al., 
1992).  Warfarin, an anticoagulant, can inhibit the synthesis of vitamin K by interfering with the 
reducing of oxidized vitamin K to the reducted vitamin K.  
Osteocalcin (bone Gla protein) was the first extrahepatic vitamin K-dependent protein 
found in bone.  It is secreted by osteoblasts and contains three Gla residues, which facilitate the 
binding of mineral hydroxyapatites (Booth et al., 2012).  Knockout mice with insufficient 
osteocalcin have been found to have increased bone density (Ducy et al., 1996).  Matrix Gla 
protein (MGP) is another vitamin K-dependent protein secreted by osteoblasts, as well as 
chondrocytes and vascular smooth muscle cells.  It is related to the organic matrix and calcium 
mobilization.  Extensive arterial calcification has been found in MGP dicifient mice, which 
suggests MGP is an important calcification inhibitor (Luo et al., 1997).  The inhibition activity 
may be due to its binding to bone morphogenetic protein-2 (BMP-2) .  BMP-2 is a growth factor 
that converts preosteoblast into bone-forming cells (Abedin et al., 2004).   
The vitamin K-dependent protein Gas6 has been shown to be associated with cellular 
growth by binding to Axl receptor, a tyrosine-protein kinase receptor.  Gas6 can activate Axl 
tyrosine phosphorylation and enhace cell migration and growth.  Li et al.(1996) reported that γ-
carboxylated Gas6 has growth factor effects on Schwann cells and smooth muscle cells in the 
central nervous system, and lack of γ-carboxylated Gas6 may be associated with the 
pathogenesis of Alzheimer’s disease. 
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Mechanism of Carotenoid, Phylloquinone, and Tocopherol Absorption 
Absorption of fat-soluble micronutrients from vegetables into the blood circulation starts 
with the mechanical and enzymatic break down of plant matrices by which carotenoids and fat-
soluble vitamins are transferred from the food matrix into the lipid droplets in the stomach.  The 
carotenoids and fat-soluble vitamins are then transferred from the lipid droplets into self 
assembled intestinal dietary mixed micelles.  Micelles are composed of phospholipids, bile salts, 
dietary lipids, and their hydrolysis products, including monoglycerides, diglycerides, and free 
fatty acids.  Bile salts, the salt form of bile acids, are synthesized in the liver and secreted by the 
gallbllader.  Bile salts and phospholipids exhibit amphipathic properties and reversibly form the 
exterior of micelles at neutral pH, and lipophilic compounds such as  monoglycerides, 
diglycerides, free fatty acids, cholesterols, as well as fat-soluble micronutrients are incoporated 
into micelle hydrophobic interior.  After incorperations into micelles, the fat-soluble 
micronutrients are uptaken by the enterocytes, incorporated into chylomicrons and transferred 
into the blood circulation via the lymphatic system.  Although the mechanism of fat-soluble 
micronutrient aborption by the enterocytes is not completely understood, it has been considered 
to invlove simple diffusion and receptor-mediated transport.   
 
Simple diffusion 
Carotenoid absorption has long been thought to occur by simple diffusion.  In 
unanesthetized rats, β-carotene absorption rate linearly responded to its concentration in the 
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perfusate from 0.5 to 11 μmol/L (Hollander et al., 1978).  Also, the β-carotene absorption was 
enhanced when simple diffusion was facilitated by increasing perfusate hydrogen ion 
concentration and perfusate flow rate, as well as by adding different types of fatty acids 
(Hollander et al., 1978).  The concentration dependence of β-carotene uptake also has been found 
in the rat small intestinal cells (Scita et al., 1992) and Caco-2 cells (Garrett et al., 1999).  The 
former showed no saturation up to 25 μmol/L β-carotene, and the latter indicated that β-carotene 
content increased when culture medium contained 2 to 27 μmol/L β-carotene.  Similarly, 
intestinal absorption of tocopherols is also assumed to be by simple diffusion.  Intestinal 
perfusion studies in rats have shown significantly higher intestinal permeability for α-tocopherol 
compared with γ-tocotrienol, which mainly contributes to the higher bioavailability of α-
tocopherol (Abuasal et al., 2012). 
 
Receptor-mediated transport  
Although intestinal absorption of fat-soluble micronutrients has been considered for a 
long time as a passive process, it has recently been revealed that several lipid transporters are 
involved in mediating carotenoid and fat-soluble vitamin intestinal uptake.  The first identified 
transporter is the scavenger receptor class B type I (SR-BI), which is a single-chain 
trasmembrane glycoprotein expressed at the brush border membrane of enterocytes from the 
duodenum to the colon (Lobo et al., 2001).  SR-BI is able to bind lipoproteins and facilitate the 
selective uptake of lipophilic compounds including cholesterol, phospholipids, and triglyceride 
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hydrolysis products (Terpstra et al., 2000; Hauser et al., 1998; Bietrix et al., 2006).  It has been 
identified that SR-BI plays a role in regulating the intestinal absorption of α-carotene, β-carotene, 
lycopene, lutein, zeaxanthin, and vitamin E (van Bennekum et al., 2005; During et al., 2005; 
Moussa et al., 2008; Reboul et al., 2005; Reboul et al., 2006).   
Cluster determinant 36 (CD36) is another scavenger receptor involved in fat-soluble 
micronutrient uptake.  Similar to SR-BI, CD36 is a single chain-membrane glycoprotein found in 
the brush border membrane of the duodenum and jejunum (Terpstra et al., 2000).  It has been 
reported that CD36 plays a key role in fatty acid uptake in the intestine, adipose tissue, and 
muscle.  In CD36-null mice, intestinal lipid secretion and catabolism rate of chylomicrons in the 
blood were reduced after a high-fat intake (Drover et al., 2005).  Although lipid secretion was 
decreased, the accumulation of chylomicrons in the blood masked this phenomenon and resulted 
in postprandial hypertriglyceridemia.  It was assumed that CD36 regulated secretion and 
clearance of intestinal lipoproteins.  van Bennekum et al. (2005) firstly reported that CD36 was 
associated with β-carotene uptake in transfected COS-7 cells and mouse brush border membrane 
vesicles.  Sakudoh et al. (2010) further showed that the selective delivery of carotenoid depended 
on a CD36-related protein, Cameo2, in Bomyx mori.  In addition, genetic variants in CD36 are 
associated with plasma lutein content in humans (Borel et al., 2011). More recently, CD36 was 
shown to facilitate the uptake of lycopene and lutein in mouse adipocytes and adipose tissue 
cultures (Moussa et al., 2011).   
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Niemann-Pick C1-like1 (NPC1L1) is a polytopic protein expressed in various human 
tissues, such as the liver and brush border membrane of the intestine (Davies et al., 2000; 
Altmann et al., 2004; Davies et al., 2005; Garcia-Calvo et al., 2005).  It is the major cholesterol 
and phytosterol transporter in the intestine, which contributes 60% of dietary cholesterol uptake 
(Altmann et al., 2004; Davies et al., 2005; Davis et al., 2004).  NPC1L1 also has been shown to 
interact with α-tocopherol and γ-tocotrienol and play a role in their absorption (Narushima et al., 
2008; Abuasal et al., 2010).  Further NPC1L1 kinetic studies demonstrated significant lower Vmax 
and Km values for γ-tocotrienol compared to α-tocopherol.  The role of NPC1L1 in carotenoid 
absorption is not completely clear (During et al., 2005).  Ezetimibe, an inhibitor of cholesterol 
transporter, was firstly shown to have an inhibition function in absorption of α-carotene, β-
carotene, β-cryptoxanthin, lycopene, lutein, and zeaxanthin in Caco-2 cells (During et al., 2005).  
However, the following study demonstrated neither ezetimibe nor an anti-human NPC1L1 
antibody reduced lycopene uptake in Caco-2 cells (Moussa et al., 2008).  Additional studies are 
thus worthwhile to investigate these discrepancies. 
On the basolateral side of enterocytes, another transmembrane transporter ATP-binding 
cassette-A1 (ABCA1) is expressed.  It medicates basolateral efflux of tocopherols.  Besides 
incorporating into chylomicrons, newly absorbed tocopherols also can be secreted in nascent 
HDL.  This process depends on ABCA1 (Reboul et al., 2009; Anwar et al., 2007).  Reboul et al. 
(2009) reported that no secretion of α-tocopherol in chylomicrons was observed when lipids are 
absent, and Anwar et al. (2007) suggested tocopherols were mostly incorporated into HDL in the 
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absence of oleic acid.  In humans, ABCA1 also is found in the retinal pigment epithelium.  Its 
gene variant is associated with retinal pigment optical density level response to lutein 
supplementation (Yonova-Doing et al., 2013).  In chicks that have a recessive mutation in 
ABCA1 resulting in a severe HDL deficiency, the plasma lutein content was only 9% of control 
level (Connor et al., 2007).  It is very likely that ABCA1 may also be involved in lutein efflux 
through enterocytes.  
 
Distribution of Carotenoids, Tocopherols, and Phylloquinone in  
Plasma Lipoproteins 
In humans, carotenoids are mostly transported in the low-density lipoproteins (LDL) and 
high-density lipoproteins (HDL).  The hydrocarbon carotenoids are different from the 
xanthophylls in the relative distribution between LDL and HDL.  The former (e.g., α- and β-
carotene) are mainly detected in LDL, whereas the latter (e.g., zeaxanthin and lutein), which are 
more polar, are found in both HDL and LDL (Stahl et al., 2002).  Recently, increasing studies 
emphasized the importance of HDL in the transport and retinal uptake of lutein (Loane et al., 
2010; Mutungi et al., 2009; Wang et al., 2007).  Moreover, lutein has been reported to exchange 
between human very low-density lipoprotein (VLDL) and HDL, whereas no exchanges were 
observed in α-carotene, β-carotene, and lycopene (Tyssandier et al., 2002).  
The major carriers of tocopherols are HDL and LDL with similar proportions, and less 
than 20% of tocopherols are carried in VLDL and other lipoproteins (Perugini et al., 2000).  The 
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transfer of α-tocopherol between circulating lipoproteins occurs either spontaneously or with 
assistance of plasma phospholipid transfer protein (PLTP) (Kostner et al., 1995).  Spontaneous 
transfer is slow and only can account for little portion of the high exchange/transfer rates that 
have been demonstrated in vivo.  PLTP has the ability to transfer various 
amphipathic/hydrophobic compounds, including phospholipids, diacylglycerides, unesterified 
cholesterol, and tocopherols, between lipoproteins in the blood circulation (Tzotzas et al., 2009).   
Similar to carotenoids and tocopherols, phylloquinone is mainly distributed between LDL 
and HDL with approximately equally proportion, and less amount of phylloquinone is carried by 
IDL (Schurgers et al., 2002; Lamon-Fava et al., 1998).  
 
Factors Influencing the Bioavailability of Carotenoids, Tocopherols and 
Phylloquinone Absorbed from Vegetables 
The bioavailability of fat-soluble micronutrients is influenced by multiple factors.  These 
factors can be classified as host-related factors or dietary factors (Yonekura et al., 2007).  The 
digestion and absorption of fat-soluble micronutrients are tightly associated with the health status 
of individuals, which include gut health, nutritional and physiological status, lifestyle, and 
genotype.  This review is mainly focused on dietary factors that affect the bioavailability of fat-
soluble micronutrients in vegetables. 
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Food matrix and food processing 
Vegetables, especially green leafy vegetables, are the primary sources of fat-soluble 
micronutrients, including carotenoids, tocopherols, and phylloquinone in the U.S diet 
(Eitenmiller et al., 1995; Murphy et al., 1990; Maras et al., 2004).  However, the bioavailability 
of fat-soluble micronutrients is rather low in raw vegetables.  One of the reasons is that the fat-
soluble micronutrients embedded in the matrix of vegetables are more difficult to be released 
compared with those in supplements.  To improve their bioavailability, food processing, e.g. 
heating and mechanical treatments, is often applied, which facilitates the release of fat-soluble 
micronutrients from the food matrix by disrupting the plant cell wall and organelles.  Rock et al. 
(1998) reported that β-carotene plasma concentration was higher when women consumed 
thermally processed and pureed carrots and spinach versus raw carrots and spinach.  Similarly, 
lycopene AUC (area under the curve) value in chylomicrons was significantly higher when 
tomato paste was consumed compared with fresh tomatoes (Gärtner et al., 1997).  Moreover, 
food processing, including boiling, cooking, and microwaving, increased the phylloquinone 
content in carrots, spinach, as well as tomatoes (Damon et al., 2004).   
In the matrix of vegetables, carotenoids are located either in the photosynthetic organelles 
(green leafy vegetables), or as part of semi-crystalline membrane-bounded solids (carrots and 
tomatoes) (Castenmiller et al., 1998; van het Hof et al., 1998).  The differences in food matrix 
microenvironment are also critical to carotenoid absorption.  It has been demonstrated that the 
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solubilization of β-carotene from raw carrot juice to oil phase was substantially higher than that 
from raw spinach (Rich et al., 2003).   
 
Dietary fat 
Besides food processing, the absorption of fat-soluble micronutrients from vegetables is 
also improved by increasing the fat content of a meal (Stahl, 2002).  The fat intake is able to 
stimulate bile and pancreatic enzyme secretion and facilitate micelle formation.  Brown et al. 
(2004) reported that no absorption of carotenoids was observed when salads were consumed with 
fat free salad dressing, and the caroteniod absorption was higher after the consumption of salad 
with full-fat (28 g canola oil) than with reduce-fat dressing (6 g canola oil).  Likewise, serum 
phylloquinone concentration was higher when boiled spinach was consumed with 25 g butter 
versus without added fat (Gijsbers et al., 1996).  In addition, it has been demonstrated that the 
consumptions of vitamin E-fortified apples with low-fat (2.4 g fat) and regular-fat (11 g fat) 
breakfasts increase the maximal plasma concentration and AUC value of α-tocopherol by 2- and 
3-fold, respectively (Bruno et al., 2006).  However, increasing fat content seems to affect the 
bioavailability of different carotenoid species to a different extent, in particular, it has stronger 
influence on the highly lipophilic carotenes (α-carotene, β-carotene, and lycopene) compared 
with less lipophilic xanthophylls (e.g., lutein and zeaxanthin).  The β-carotene and lutein, 
released from the digesta of spinach puree containing 10% corn oil, showed no significant 
difference in micellerization in an in vitro digestion model (Ferruzzi et al., 2001).  However, in 
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the presence of relatively low amount of fat (2-3.5%), the micellerization of lutein extremely 
exceeded that of β-carotene after an in vitro simulated digestion (Garrett et al., 1999; 
Chitchumroonchokchai et al., 2004; Garrett et al., 2000).  It suggests that, with insufficient 
dietary fat, the micellerization of the more lipophilic carotenes is limited, whereas the less 
lipophilic xanthophylls seem to be more freely released from the food matrix to oil phase and 
mixed micelles.   
Furthermore, unprocessed vegetable consumption seems to require more fat to achieve 
the optimal absorption of fat-soluble micronutrients.  As mentioned above, the chylomicron 
carotenoid content was higher when salad vegetables were consumed with 28 g canola oil than 
with either 6 g or 0 g canola oil (Brown et al., 2004).  Similarly, the addition of avocado or 
avocado oil significantly increased the absorption of α-carotene, β-carotene, and lutein from 
salad and salsa (Unlu et al., 2005).  In contrast, when α- and β-carotene supplements were 
consumed with a meal containing 3 g or 36 g dietary fat, no significant differences in plasma α- 
and β-carotene contents were observed between the low- and high-fat groups (Roodenburg et al., 
2000).   
The fat composition also plays a role in the bioavailability of fat-soluble micronutrients. 
Long-chain triglycerides are able to promote chylomicron formation, whereas medium-chain 
triglycerides diminish chylomicron formation.  Therefore, the presence of long-chain 
triglycerides in both the first and second meals significantly enhanced carotenoid absorption 
compared with the presence of medium-chain triglycerides (Borel et al., 1998).  Several studies 
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also have shown the degree of unsaturation in fatty acids can affect carotenoid absorption.  The 
absorption of β-carotene was higher when a β-carotene supplement was ingested with beef tallow 
than with sunflower oil (Hu et al., 2000).  Also, micellar oleic, but not linoleic acid, have been 
reported to enhance β-carotene absorption and its cleavage into retinol in rats (Raju et al., 2006).  
Furthermore, Huo et al. (2007) reported that the efficiency of lutein uptake by Caco-2 cells was 
significantly higher from that of micelles generated during the in vitro digestion of salad in the 
presence of triolein (monounsaturated fatty acid) compared with trioctanoin (saturated fatty 
acid), while the uptake of β-carotene, α-carotene and lycopene were not affected by the degree of 
unsaturation of the fatty acids in the added triglycerides.  Few human studies have investigated 
the role of the degree of unsaturation of fatty acids in the absorption of lutein, α-carotene, and 
lycopene.  It is likely that the degree of unsaturation in fatty acids may play a role in the 
bioavailability of carotenoids.  According to the in vitro study of Huo et al. (2007), lutein may 
have a different response to the degree of unsaturation of fatty acids in vivo as compared with -
carotene, α-carotene, and lycopene. 
 
Phospholipids and other lipids 
The absorption of fat-soluble micronutrients involves gastric oil phase and dietary mixed 
micelles.  Phospholipids, as one of the components of mixed micelles and an emulsifier for oil, 
have been studied for their bioavailability enhancing effects.  They commonly exist in both fresh 
and processed food matrixes, especially phosphatidylcholine, which is also the major form of 
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phospholipids in bile.  Under normal conditions, most dietary and biliary phosphatidylcholine is 
hydrolyzed by the action of phopholipase A2 to produce lysophosphatidylcholine.  It has been 
shown that lysophosphatidylcholine, a common component in soy lecithin, can enhance the 
bioavailability of β-carotene, lutein, and α-tocopherol in rats, mice, and Caco-2 human intestinal 
cells (Lakshminarayana, 2006; Sugawara, 2001; Baskaran, 2003; Koo, 2001).  Moreover, the 
acyl chain length of phospholipids is also a critical factor influencing their effects on the 
bioavailability of fat-soluble micronutrients (Yonekura, 2006).  Yonekura et al. (2006) reported 
that medium-chain phosphatidylcholine and medium-to-long-chain lysophosphatidylcholine 
increased β-carotene uptake, whereas long-chain phosphatidylcholine inhibited and short-chain 
phosphatidylcholine as well as short-to-medium-chain lysophosphatidylcholine had no effects on 
the β-carotene uptake. 
Sucrose polyesters are often used as nonabsorbable fat replacers because they cannot be 
hydrolyzed by gastric and pancreatic lipases.  They are able to partition fat-soluble 
micronutrients from mixed micelles and consequently decrease the nutrient uptake (Weststrate 
and van het Hof, 1995, Koonvitsky et al., 1997, Schlagheck et al., 1997).  However, due to the 
relatively less lipophilic nature of xanthophylls, their absorption is less inhibited by sucrose 
polyesters when compared to β-carotene (Schlagheck et al., 1997; Broekmans et al., 2003).   
Plant sterols and stanols have been reported to lower plasma cholesterol levels in humans 
(Nguyen et al., 1999). However, they can compete with fat-soluble micronutrients for the 
incorporation in mixed micelles.  In the presence of β-sitosterol, β-carotene absorption was 
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diminished to approximately 50% in Caco-2 cells, and both of them were completely dissolved 
(Fahy et al., 2004).  Also, the plasma TRL β-carotene content was reduced by 50% when human 
subjects consumed a single meal containing free or esterified plant sterols (Richelle, 2004).  
 
Dietary fiber 
Dietary fiber, especially soluble fiber, has been considered to have an inhibitory role in 
the absorption of lipophilic compounds, such as cholesterol (Brown et al., 1999).  Similarly, as 
hydrophobic bioactive food components, the absorption of carotenoids was diminished by some 
types of fibers in humans (Riedl et al., 1999; Rock et al., 1992), rats (Zanutto et al., 2002), chicks 
(Erdman et al., 1986), and Mongolian gerbils (Deming et al., 2000).  The mechanism of the 
inhibitory effects of fiber on carotenoid absorption has not been completely elucidated.  Such 
mechanisms might include: 1) influencing the pancreatic enzyme activity and consequently 
inhibiting micelle formation; 2) slowing the diffusion of micelles to the enterocytes by increasing 
the viscosity and volume of the intestinal contents; 3) diminishing second meal effects by 
altering enterocyte renewal (Riedl et al., 1999).  On the other hand, in one human study, 
volunteers were given a supplement containing carotenoids and α-tocopherol with or without 
various types of fiber, and significantly lower AUC values for carotenoids were observed in the 
fiber groups, whereas no differences were found for α-tocopherol AUC values (Riedl et al., 
1999).  Animal studies suggested that the effects of dietary fiber on vitamin E absorption might 
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be apparent only if the fiber intake reached an “effective level” (De Lumen et al., 1982; Schaus 
et al., 1985).   
Species and stereoisomers of fat-soluble micronutrients 
As mentioned above, dietary lipids do not affect all carotenoid species to the same 
degree.  Increasing the fat content of the meal efficiently enhances the absorption of the more 
lipophilic carotenes, whereas the transfer of the less lipophilic xanthophylls from the oil phase to 
micelles occurs much more easily in low-fat dietary conditions (Yonekura et al., 2007).  Thus, 
different carotenoid species may require different amounts and/or types of lipids for optimal 
absorption.  Within one carotenoid species, the bioavailabilty of different stereoisomers may be 
different.  The cis-isomer of lycopene has been shown to be more bioavailable than all-trans 
lycopene, which may be due to the shorter length of the cis-isomer which facilitates 
micellerization and uptake by intestinal cells (Boileau et al., 2002; Failla et al., 2008).  However, 
the preferential uptake of the all-trans β-carotene, rather than the cis-isomers, was observed in 
several human studies (Gaziano et al., 1995; Stahl et al., 1993; You et al., 1996).  Moreover, the 
α-tocopherol constitutes more than 90% of vitamin E in the human body (Gohil et al., 2008; 
Brigelius-Flohe et al., 1999; Burton et al., 1990), even though γ-tocopherol is the predominant 
form of vitamin E in the diet (Rigotti et al., 2007).  The limited bioavailability of γ-tocopherol is 
caused by its low affinity of α-tocopherol transfer protein (α-TTP), which is only 9% compared 
with RRR-α-tocopherol (Hosomi et al., 1997).  Likewise, the high α-TTP affinity of RRR-α-
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tocopherol also contributes to its 2-fold higher plasma concentration after a single dose or 8 
consecutive daily doses when compared to all-rac-α-tocopherol (Burton et al., 1998). 
 
Apolipoprotein B and Apolipoprotein B-containing Lipoproteins 
Apolipoprotein B (apoB) is a large plasma protein that binds to the surface of lipoproteins 
and plays an essential role in the assembly of triglyceride-rich lipoproteins.  ApoB occurs in two 
isoforms, apolipoprotein B-48 (apoB-48) and apolipoprotein B-100 (apoB-100).  They are 
encoded by the same gene on chromosome 2 (Welty et al., 1999; Veniant et al., 1999).  In 
humans, apoB-48 is secreted by the intestine as a result of a post-transcriptional mRNA editing 
catalyzed by the apoB editing complex 1 (apoBEC-1).  This enzyme converts codon 2153 to a 
stop codon (UAA) that truncates the polypeptide at 48% of its full length.  The full length apoB, 
apoB-100, is primarily synthesized by the liver and contains 4536 amino acids.   
Unlike all other apolipoproteins, apoB cannot exchange between lipoproteins, and it 
remains with the apoB-containing lipoprotein through its entire metabolic process.  Therefore, 
apoB-48 and apoB-100 are regarded as reliable markers of intestinal and hepatic origin 
lipoprotein particles, respectively (Phillips et al., 1997; Karpe et al., 1994; Chan et al., 1992).  
ApoB-containing lipoproteins have long been referred to as chylomicrons and VLDL (Lemieus 
et al., 1998; Karpe et al., 1994).  Chylomicrons are lipoprotein particles of intestinal origin, 
which transport newly absorbed lipids and fat-soluble nutrients.  VLDL is synthesized by the 
liver, and transports endogenous lipids.  VLDL can be converted to intermediate-density 
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lipoproteins (IDL) and LDL by the action of lipoprotein lipase.  However, data from cell culture, 
rat liver perfusion, and human studies demonstrate that the liver has the capability of producing a 
wide spectrum of apoB-100 containing lipoproteins from VLDL down to LDL (Marsh et al., 
1976).  Recently, apoB-48 has also been found in lipoproteins with various sizes and densities, 
including VLDL, IDL, and LDL (Campos et al., 2005; Cartwright et al., 2001; Zheng et al., 
2006; Johanson et al., 2004; Mero et al., 2000; Battula et al., 2000).  By labeling apoB-100 and 
apoB-48 with trideuterated leucine, Zhang et al. (2006) reported that the liver and intestine were 
capable of secreting apoB-100- and apoB-48-containing lipoproteins, respectively, with a range 
of sizes from chylomicron-sized down to IDL-sized particles. The production rate of apoB-100 
in the liver was higher than that of apoB-48 in the intestine (Zheng et al., 2006).  Among the 
apoB-containing lipoproteins, this review will focus on chylomicrons and VLDL. 
 
ApoB synthesis and apoB-containing lipoprotein assembly 
As mentioned above, apoB transcriptional regulation is tissue-specific.  In enterocytes of 
all mammals, apoB-48 is synthesized as the 48% of apoB-100 fragment due to the action of 
apoBEC-1.  With the absence of apoBEC-1 in human liver, only apoB-100 is assembled into 
VLDL.  ApoB translation is mainly regulated by 5' and 3' untranslated regions (UTRs) of apoB 
mRNA.  In the 5' UTR of apoB mRNA, about 76% of the bases are either guanine or cytosine.  
The GC-rich regions are able to form stable secondary structures (Kozak et al., 1991).  The 3' 
UTR of apoB mRNA is rich in adenine and uracil, and the AU-rich regions can also form 
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secondary structures that may play a role in the regulation of mRNA stability (Day and Tuite, 
1998; Pontrelli et al., 2004).  Several studies have investigated the effects of 5' and 3' UTRs in 
the translation of apoB by binding the UTRs with a luciferase reporter gene or apoB15 cDNA 
(Pontrelli et al., 2004; Sidiropoulos et al., 2005, 2007).  The results suggested that the 5' UTRs 
facilitated apoB translation, but, in contrast, the 3' UTR had an adverse impact on the apoB 
translation by reducing the stability of apoB mRNA (Pontrelli et al., 2004; Sidiropoulos et al., 
2005, 2007).  Furthermore, insulin can also negatively affect apoB translation by the action of 
insulin-sensitive factor.  The 110 kDa insulin-sensitive factor is able to bind the first 64 
nucleotides of the 5' UTR that has been demonstrated to be the response region of apoB mRNA 
to insulin, and the binding subsequently induces reduction in apoB translation (Sidiropoulos et 
al., 2005, 2007).  This process is assumed to be associated with phosphoinositide 3 kinase and 
mTOR pathways, because the binding of the insulin-sensitive factor to the 5' UTR and the 
insulin inhibition of apoB translation were diminished when HepG2 cells were treated with 
either phosphoinositide 3 kinase inhibitor (wortmannin) or mTOR inhibitor (rapamycin) 
(Sidiropoulos et al., 2007).   
After translation of a signal peptide consisting of 24-27 amino acids, the nascent apoB 
chain and ribosomes are transferred to the rough endoplasmic reticulum (ER) (Boerwinkle and 
Chan, 1989).  With sufficient lipid ligands, the nascent apoB is translocated into the ER lumen 
via a proteinaceous channel, known as the translocon (Chen et al., 1998).  The translocon is 
primarily composed of the Sec61 protein and binds to ribosomes with high affinity (Alder et al., 
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2004; Rapoport et al., 2007).  Following translocation, apoB translation continues.  During and 
after translation, apoB is lipidated by the microsomal transfer protein (MTP) and subsequently 
forms a pre-VLDL (Olofsson et al., 2000; Gordon et al., 2000; Shelness et al., 2005).  MTP is a 
membrane-associated heterodimer of protein disulfide isomerase (PDI) and a 97 kDa polypeptide 
subunit that improves the delivery of phospholipids, cholesteryl esters, and triglyceride to apoB 
(Hussain et al., 2003; Shoulders et al., 2005).  Individuals with a mutation of the MTP gene have 
abetalipoproteinmia, which is characterized by a deficiency of VLDL formation (Di Leo et al., 
2005).  Although MTP plays an indispensable role in VLDL formation, a recent study implies 
that MTP is not required for apoB translocation in McA-RH7777 cells (Dashti et al., 2007).  In 
addition to MTP, apoB co-translationally and post-translationally interacts with various 
molecular chaperones, including cyclophilin, PDI, BiP (an Hsp70 chaperone), Grp94 (an Hsp90 
chaperone), calnexin, and calreticulin (chaperone-like lectins) (Chen et al., 1998; Tatu et al., 
1997; Rashid et al., 2002; Stillemark et al., 2000; Zhang et al., 2003; Qiu et al., 2005).  Most of 
the molecular chaperones may be associated with apoB posttranslational modification or 
degradation, or facilitate insertion of apoB into multiprotein complexes; however, the complete 
mechanism of each chaperone effect on apoB is not clear (Brodsky et al., 2008).   
Following the formation of pre-VLDL, the primordial lipoprotein particles are packed 
and transported by coatomere Protein Ⅱ (COPⅡ) to the Golgi apparatus (Gurkan et al., 2006).  
This process is stimulated by a GTPase known as Sar1.  Mutations in Sar1 are responsible for 
chylomicron retention disease, which is characterized by chylomicron deposition in intestinal 
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cells (Jones et al., 2003).  Likewise, Sar1 also plays an essential role in apoB export from ER in 
rat hepatoma McA-RH7777 cells (Gusarova et al., 2003).  In the Golgi apparatus, the primordial 
lipoprotein particles were further lipidated to achieve VLDL density, by which VLDL is formed.  
The final VLDL lipidation is mediated by phospholipase D1 and extracellular signal regulated 
kinase 2 (ERK2).  They facilitate the formation of VLDL by increasing the production of 
cytosolic lipid droplets that deliver additional lipids into the Golgi apparatus.  
 
ApoB degradation 
ER-associated degradation 
ER-associated degradation (ERAD) is a cellular pathway that recognizes misfolded 
secretory proteins in the ER and subsequently induces their ubiquitin-dependent degradation by 
the proteasome (Brodsky et al., 2007).  The ERAD is able to prevent the development of 
cytotoxic aggregates caused by concentrated misfolded proteins.  When the concentration of 
misfolded proteins increases rapidly in the ER and exceeds the capability of ERAD, the unfolded 
protein response (UPR) is activated by transmembrane UPR sensors (Schroder et al., 2005; Ron 
et al., 2007).  The UPR stimulates the enhancement of ER chaperone synthesis, ERAD 
efficiency, as well as other degradation pathways.  In addition to ER quality control, the ERAD 
also has the ability to regulate metabolic processes.  When lipid loading is limited, which may be 
caused by low MTP activity or low lipid availability, apoB is targeted for ubiquitination and 
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subsequently degradation by the proteasome during translation process (Benoist et al., 1997; 
Dixon et al., 1991; Zhou et al., 1998).   
 
Polyunsaturated fatty acid-induced degradation 
The apoB degradation can also happen after the ER exit of pre-VLDL, known as PERPP 
(post-ER presecretory proteolysis).  Dietary polyunsaturated fatty acids (PUFAs) are able to 
trigger PERPP and then decrease VLDL levels (Fisher et al., 2001).  In vitro and animal studies 
have shown that in the presence of PUFAs, apoB is damaged by lipid peroxides, and aggregates 
are formed and subsequently degraded by autophagy (Pan et al., 2004).  This process most likely 
occurs in the Golgi apparatus, because pre-VLDL requires further addition of lipids in the Golgi 
in which VLDL may be exposed to PUFAs (Brodsky et al., 2008).   
 
Insulin-induced degradation 
Insulin, as an essential peptide hormone, is involved in lipid metabolism by inhibiting 
hormone-sensitive lipase, promoting storage of triglycerides, as well as diminishing VLDL 
production inthe liver.  Acute increases in insulin reduce apoB synthesis and VLDL secretion in 
HepG2 cells, rat and human hepatocytes, and rats (Patsch et al., 2004; Sparks et al., 1986; 
Pullinger et al., 1989; Salhanick et al., 1991; Durrington et al., 1982; Chirieac et al., 2000).  
These inhibitory effects of insulin primarily depend on PI3K (phosphatidylinositol 3-kinase) 
activity (Phung et al., 1997).  Insulin is able to activate PI3K by tyrosine phosphorylation of 
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insulin receptor substrates.  The activated PI3K subsequently: 1) inactivates protein phosphatase 
1B (PTP1B), which increases the expression of a cysteine protease ER60 and consequently 
promotes apoB degradation; 2) suppresses the activities of FoxO1 and Foxa2, two transcription 
activators of MTP, and then MTP expression is reduced; 3) decreases phosphatidylinositol 
biphosphate (PIP2) that is responsible for activating phospholipase D1 and ARF-1, two factors 
required in pre-VLDL formation (Vergès et al., 2010).  The PUFAs-induced PERPP may also 
play a role in the effects of insulin on the production of apoB-containing lipoproteins since it has 
been observed that PUFA-rich diets increase insulin sensitivity (Riserus et al., 2008; Galgani et 
al., 2008). 
 
ApoB-100 synthesis in human intestine 
It is universally known that human apoB-48 is primarily secreted by the intestine and 
apoB-100 is the predominant isoform in human liver.  However, the detection of apoB-100 in the 
human intestine by using anapoB-100 cDNA probe (Knott et al., 1985) raises a question: Can the 
human intestine synthesize apoB-100?  Several in vitro studies reported Caco-2 cells were able 
to produce apoB-100 (Hughes et al., 1987; Lee et al., 1988).  A human intestinal organ culture 
study indicated apoB-100 represented 16 ± 3% of the intestinal apoB mRNA, whereas apoB-100 
only contributed 3-5% of newly synthesized intestinal apoB (Hoeg et al., 1990).  The synthesis 
of apoB-100 may be associated with age.  Immunoprecipitates of 11-week fetal intestine showed 
major radioactivity incorporation into apoB-100 and little incorporation into apoB-48.  The 
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intestine from 16 week fetuses incorporated radioactivity into both apoB-100 and apoB-48, 
whereas adult intestine immunoprecipitates only contained radioactivity in apoB-48 (Glickman 
et al., 1986).  Another immunoprecipitate study, in which intestinal biopsy samples were 
obtained from 6 children aged 3 months to 8 years, reported radioactivity primarily in apoB-48, 
but a relatively small amount was detected in apoB-100 (Levy et al., 1990).  In the same study, 
apoB-100 was found in thoracic duct lymph chylomicrons donated by a 5-year old boy with 
severe hypertension (Levy et al., 1990).  This finding was consistent with studies of Kane et al. 
(1980) and Ruf et al. (1999), where apoB-100 presented in chylomicrons from thoracic duct 
lymph samples obtained from five normolipidemic patients and a patient undergoing thoracic 
surgery, respectively.  However, hepatic lymph contributes about 25 to 50% of lymph flowing 
through the thoracic duct (Ohtani et al., 2008).  The detection of apoB-100 in thoracic duct 
lymph might be caused by contamination of hepatic apoB-100-containing large VLDL presented 
in the thoracic duct lymph and being collected with chylomicrons.  To examine this possibility, 
Lock et al. (1983) investigated apoB isoforms in chylomicrons isolated from a male patient with 
chyluria.  Chyluria is a medical disorder with symptoms of chyle urine and lymph channel 
blocking.  The apolipoprotein composition in urine chylomicrons was determined by using 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) with Coomassie Blue 
staining.  Lock et al (1983) concluded that the apoB-48 is virtually the only apoB in 
chylomicrons.  However, a weak band in the apoB-100 size position was observed in urine 
chylomicrons isolated after an overnight fasting.  Although the intestine has the ability to 
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synthesize apoB-100, it tends to choose apoB-48 to form chylomicrons.  Mice with apobec-1 
gene knock out, whose intestine secreted only apoB-100, had a reduction of chylomicron 
secretion into the lymphatic system and triglyceride accumulation in the enterocytes after being 
fed a large dose of lipids (Lo et al., 2008).  The synthesis rate of apoB-100 in human intestine 
still needs to be quantified, and whether it is regulated by diet and insulin is not clear. 
 
Factors affecting apoB secretion and apoB-containing lipoprotein assembly 
Dietary fat 
As mentioned above, dietary PUFAs (polyunsaturated fatty acids), particularly the n-3 
fatty acids enriched in fish oil, are able to reduce VLDL levels by PUFAs-induced post ER 
nonproteasomal degradation. A VLDL apoB-100 kinetics study reported that triglyceride level 
was decreased in 10 normal male subjects after consuming a daily fish oil supplement for four 
weeks.  The triglyceride reduction is due to a decreased production rate of VLDL apoB-100 
(Bordin et al., 1998).  In addition, dietary fat may affect VLDL particle size (Stacpoole et al., 
1991).  When normal subjects consumed very low fat diets, more apoB-100 was secreted with 
VLDL/IDL-like particles, whereas high fat diets increased larger VLDL particle secretion.  Also, 
the fractional clearance rate of VLDL/IDL was increased in both normal and familial 
hypercholesterolemic subjects after they consumed a very low fat diet.  
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Aging  
Dietary fat is not the only factor regulating apoB and apoB-containing lipoprotein 
secretion.  The magnitude of apoB-100 in VLDL, IDL, and LDL has been positively correlated 
with age in normolipidemic male subjects (Millar et al., 1995).  ApoB-100 kinetic analyses also 
revealed that aging was linked with an increased production of VLDL and a decreased fractional 
clearance rate of apoB-100 in IDL and LDL in the fed state.  This is supported by an earlier 
study with radiolabeled LDL apoB, which reported that the LDL apoB fractional catabolic rate 
was higher in young male subjects (20-39 y) compared withold male subjects (60-80 y) 
(Ericsson, 1991).  Besides aging, postmenopausal status has been shown to result in greater 
postprandial lipid responses in women (Cohn et al., 1988; van Beek et al., 1999; Masding et al., 
2003).  In sequential dietary studies recently conducted at Reading University, postprandial data 
from 98 healthy UK female adults were pooled and analyzed (Jackson et al., 2008).  The 
investigators reported that triglyceride absorption and maximal triglyceride concentration were 
augmented in postmenopausal women, and the most evident difference in triglyceride absorption 
was observed between the younger and the older premenopausal women.  Normal apoB secretion 
depends on the availability of lipids; therefore, it could be hypothesized that menopausal status 
might affect apoB and apoB-containing lipoprotein metabolism by regulating the postprandial 
lipid responses.  
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Gender 
In several kinetic studies, a gender difference in lipoprotein metabolism was noted.  
Women have been shown to have higher triglyceride-rich lipoprotein and LDL-apoB fractional 
catabolic rates than men, whereas no significant differences are found in production rates 
(Matthan et al., 2008; Watts et al., 2000).  In addition, gender differences observed in younger 
subjects were more significant than in older subjects (Stanhope et al., 2011; 2009).  The younger 
male adults exhibited greater fasting triglyceride and apoB responses after 2 weeks of sugar 
consumption, whereas the responses in postprandial triglyceride and apoB were comparable 
between the genders (Stanhope et al., 2011).  It was suggested that the gender difference in 
lipoprotein metabolism may reflect VLDL clearance rate rather than its secretion rate.  
 
ApoB and apoB-containing lipoprotein kinetics 
Kinetic studies of apoB-containing lipoproteins began with chylomicrons by labeling the 
triglyceride component.  Chylomicron triglyceride was found to be cleared from the blood within 
minutes in healthy subjects, whereas the clearance rate was relatively slow in subjects with 
coronary heart disease (Nestel et al., 1964; Grundy et al., 1976).  By labeling chylomicrons with 
either retinyl palmitate or iodinated protein components, subsequent studies reported the half-
time of chylomicrons in blood was as short as 15-30 min (Berr et al., 1984; Cortner et al., 1987; 
Karpe et al., 1997; Schaefer et al., 1978; Stalenhoef et al., 1984; Schaefer et al., 1986).  
Although, in the early stages of kinetic investigations, radioiodinated apoB-48 and apoB-100 
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were shown to be depleted within 15 min and 30 min, respectively, in normal subjects 
(Stalenhoef et al., 1984), the apoB-48 and apoB-100 were radiolabeled in vitro after isolation 
from plasma.  To avoid radiation hazards and exogenous labeling, amino acid precursors labeled 
with stable isotopes are now widely used.  When apoB-48 and apoB-100 were endogenously 
labeled with stable isotopes, the catabolism of chylomicrons was found to be significantly slower 
than it had been assumed.  Several studies reported that apoB-48 had similar fractional turnover 
rate to apoB-100 in triglyceride-rich lipoproteins, with an average fractional catabolic rate (FCR) 
of four to six per day and an average residence time of 4-6 h (Lichtenstein et al., 1992; Welty et 
al., 1999; Welty et al., 2000; Batista et al., 2004; Welty et al., 2004;).  The FCR difference was 
observed in the two major VLDL subfractions (large and small VLDL); i.e., the FCR of large 
VLDL is significantly faster than that of small VLDL, but no consistent differences were found 
in the production rate (PR) between the two subfractions (Marsh et al., 2002).  Moreover, the 
postprandial PR of apoB-100 in VLDL is about twice as great as that in the fasting condition 
(Marsh et al., 2002). 
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ABSTRACT 
Background: Lecithin may influence the bioavailability of fat-soluble micronutrients.  The role 
of the large very-low-density lipoprotein (VLDLA) plasma fraction in postprandial fat-soluble 
micronutrient transport is not clearly defined.  
Objectives: This study investigated the: 1) effects of the lecithin/oil ratio in salad dressing on the 
absorption of carotenoids, phylloquinone, and tocopherols from salad vegetables and retinyl 
palmitate from intestinal metabolism of the provitamin A carotenoids; 2) roles of the plasma 
chylomicron and VLDLA fractions in the transport of the absorbed fat-soluble micronutrients. 
Design: Healthy women (n = 12) each consumed three salads with salad dressings containing: 1) 
4 g soybean oil and 0 g hydroxylated soy lecithin (Solec® 8120, Solae, St. Louis, MO); 2) 3.8 g 
soybean oil and 0.2 g Solec® 8120; or 3) 3.2 g of soybean oil and 0.8 g Solec® 8120.  The 
salads were separated by ≥ 2 wk.  Blood was collected at baseline and 2, 3.5, 5, 7, and 9.5 h 
postprandially.  Fat-soluble micronutrients in the lipoprotein fractions were analyzed by HPLC 
with coulometric array electrochemical detection.  Apolipoprotein (apo) B-48 and apo B-100 
contents in chylomicrons and VLDLA were determined by ELISA.   
Results: There were no differences among the salad dressings in the area under the curve (AUC) 
values for the fat-soluble micronutrients in the chylomicron or VLDLA fractions.  The exception 
was a decrease in the AUC for phylloquinone in the chylomicron fraction when the salad 
dressing containing 0.8 g was compared with that containing 0 g Solec® 8120 (P < 0.02).  The 
AUC values for α-carotene, β-carotene, lycopene, retinyl palmitate, and phylloquinone were 
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substantially higher in the VLDLA than in the chylomicron fraction (P < 0.05).  ApoB-48 and 
apoB-100 contents were higher in the VLDLA fraction than in the chylomicron fraction (P < 
0.0001).   
Conclusions: The hydroxylated soy lecithin in the amounts added to the salad dressing did not 
enhance the absorption of fat-soluble micronutrients.  The majority of the absorbed fat-soluble 
micronutrients and enterogenous (apoB-48) and hepatogenous (apoB-100) lipoprotein particles 
were contained within the large VLDL fraction.  Thus this VLDL subfraction has a major role in 
the transport of newly absorbed carotenoids and fat-soluble vitamins. 
 
INTRODUCTION 
Salad consumption is a major contributor to vegetable consumption in the United States 
(1).  Although the bioavailability of carotenoids and fat-soluble micronutrients is low in raw 
vegetables (2-5), the absorption is able to be improved by increasing the fat content of a meal (6, 
7).  Because high fat intakes are not recommended, one strategy is to find a lipid that is more 
efficient than triacylglycerol in increasing the bioavailability of fat-soluble micronutrients.  
Lecithin, as a structural component of mixed micelles and an excellent emulsifier, is likely to 
enhance the absorption of dietary lipids and lipophilic nutrients.  Soybean lecithin was reported 
to increase the lymphatic absorption of triglyceride in rats (8).  Also, after 10 days of lutein 
consumption with either phosphatidylcholine or lysophosphatidylcholine, the lutein contents in 
rat plasma, liver, and eyes were significantly higher than those in which lutein was consumed 
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without phospholipids (9).  However, it has not been addressed the effects of dietary lecithin on 
the bioavailability of carotenoids and fat-soluble vitamins in humans.  The exception was one 
study which showed that multiple doses of an oral preparation of phylloquinone containing 
lecithin and glycocholic acid maintained phylloquinone status in infants at least equal to that of 
an intramuscular injection (10).   
In our previous studies, after the consumption of a β-carotene dose with a fat-rich meal, we 
observed that the postprandial appearance of β-carotene and retinyl palmitate in the plasma 
chylomicron fraction coincided in time and magnitude with their appearance in large very low 
density lipoproteins (VLDLA) (11, 12).  Although the VLDLA subfraction has been used as a 
vehicle for assessing the intestinal absorption of β-carotene and its major bioconversion product, 
retinyl palmitate (11-14); there has been little systematic study of the role of VLDLA in the 
transport of other newly absorbed fat-soluble micronutrients.  The postprandial appearance of 
retinyl palmitate in VLDLA was hypothesized to be attributed to intestinal VLDL (13), but could 
also reflect the appearance of retinyl palmitate in chylomicron remnants (15).  However, 
VLDLA have long been regarded as liver-derived lipoproteins (16, 17).  Apolipoprotein B-48 
(apoB-48) and apolipoprotein B-100 (apoB-100) are reliable biomarkers of lipoprotein particles 
of intestinal and hepatic origin, respectively (18-20).  Therefore, an investigation of apoB-48 and 
apoB-100 in the plasma VLDLA fraction after a single meal could provide new insight regarding 
the origin of VLDLA.  
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The objectives of the present study were to investigate the effects of the lecithin/oil ratio in 
salad dressing on the absorption of fat-soluble micronutrients from salad vegetables.  An 
additional objective was to investigate the origin of VLDLA and the roles of the plasma 
chylomicron and VLDLA fractions in the transport of the absorbed fat-soluble micronutrients. 
SUBJECTS AND METHODS 
Subjects 
Thirteen healthy, nonsmoking, normolipidemic women, aged 18-40 y, were enrolled in this 
study.  One subject dropped out before completing the first study period due to a gastrointestinal 
problem that prevented her from consuming the test salad.  The mean (± SD) age of the 
remaining 12 subjects was 27 ± 6.9 y; the mean (± SD) body mass index (BMI; in kg/m
2
) was 
20.7 ± 3.0.  The subjects were screened initially by using a standardized questionnaire that 
addressed health and lifestyle factors.  At the time of interview, the applicants’ body weights and 
heights were measured and recorded.  Those who met the eligibility criteria donated a fasting 
blood sample for a blood biochemistry profile, blood lipid profile, and complete blood count.  
The exclusion criteria included frequent consumption of alcoholic beverages (> 1 drink/d), 
current or recent (previous 12 mo) cigarette smoking,  pregnant or planning to become pregnant 
during the study, current or recent (previous 4 mo) use of hormonal contraceptives, use of dietary 
supplements in the past 1 mo, current or recent (previous 1 mo) ingestion of plant sterols and/or 
medications known to affect lipid metabolism, body mass index (BMI) ≤ 18 and ≥ 30, known 
food allergy, and vegetarianism.  The SCOFF questionnaire was used to access whether 
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applicants had a history of restrictive eating (21).  Subjects who had 2 or more “yes” responses 
on the written questionnaire were excluded.  All procedures involving human subjects were 
approved by the Iowa State University Institutional Review Board. 
Test salads 
The test salads consisted of 48 g romaine lettuce (Classic Romaine® Salad Mix, Dole Food 
Company, Thousand Oaks, CA), 48 g fresh spinach leaves (Spinach, Dole Food Company), 66 g 
fresh, shredded carrots (Shredded Carrots, Dole Food Company), and 85 g fresh cherry tomatoes 
(NatureSweet, San Antonio, TX).  The total weight (247 g) equaled the 90
th
 percentile of the 
quantity of salad (lettuce and other vegetables) that was eaten by adults per eating occasion in the 
1994-1996 Continuing Survey of Food Intakes by Individuals (CSFII) (22).  The prepackaged 
salad vegetables were special ordered to minimize and standardize the time spent in shipment.  
The cherry tomatoes, romaine lettuce, and spinach leaves were manually sorted to achieve 
uniform color intensity from week-to-week, and thereby minimize variation in the carotenoid/fat-
soluble vitamin contents in the salads.  The green color of the romaine and spinach leaves was 
used as an indicator of chlorophyll and, by extrapolation, carotenoid contents (23).  
Representative samples of the spinach, romaine lettuce, cherry tomatoes, and carrots from the 
test salads consumed during each of the 6 weeks of the study were stored at -70°C.  The salad 
dressings were supplied by Unilever R&D (Vlaardingen, The Netherlands).  The salad dressings 
were prepared by combining 4 g of the lipid phase with 56 g of an aqueous salad dressing base 
formulation.  The lipid phase (4 g total) in the form of phylloquinone- and tocopherol-stripped 
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soybean oil contained either: 1) 0 g; 2) 0.2 g; or 3) 0.8 g hydroxylated soy lecithin (Solec® 8120, 
Solae, St. Louis, MO).  The phylloquinone and tocopherols were stripped from the soybean oil at 
Unilever R&D by using a standard short path distillation procedure.  The total phospholipid 
contents of the lipid phases were analyzed by Spectral Service (Cologne, Germany).  The 60 g 
serving of the salad dressing was chosen to simulate the typical intake of salad dressing for a 
person eating a salad as all or most of a meal.  This amount of salad dressing was chosen to 
correspond with the amount of salad vegetables; thus, 60 g was the 90
th
 percentile of the quantity 
of low-calorie and full-fat salad dressings reported by adults eating salad components at an 
eating occasion in the 1994–1996 CSFII (22).  Each salad dressing was weighed directly onto the 
salad and tossed with the salad vegetables to ensure even distribution.   
Before consuming the test salad, the subjects first drank 250 mL of water and then waited 
15 min to allow for emptying of the stomach.  Then, the test salads were consumed together with 
another 250 mL of water within a 30 min-period.  Subjects were instructed to consume the entire 
salad and then to scrape the residual salad dressing from the bowl with a spatula to ensure that all 
of the test salad was consumed. 
Experimental design 
Each subject consumed three test salads that had identical vegetable composition and 
identical aqueous base phase in the salad dressing, but different composition of the lipid phase in 
the salad dressing: 4 g of soybean oil containing 0 g of Solec® 8120, 3.8 g of soybean oil 
containing 0.2 g of Solec® 8120, or 3.2 g of soybean oil containing 0.8 g of Solec® 8120.  The 
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subjects consumed each of the three test salads according to the treatment orders of a Williams 
Latin square design (24).  The 12 subjects were each randomly assigned to one of the 6 treatment 
orders, so that each of the 6 treatment orders was represented twice.  The washout period 
between the test salads was ≥ 2 weeks.  
Blood samples were collected from a forearm vein by a licensed medical technician using a 
butterfly needle blood collection set (BD Safety-Lok TM Blood Collection Set, Becton, 
Dickinson, and Co, Franklin Lakes, NJ).  For days 1-3 of each study period, the subjects were 
instructed to avoid foods containing high amounts of carotenoids, phylloquinone, tocopherols, 
and vitamin A.  A list of foods to avoid was provided.  On day 4, the subjects consumed a 
weighed, standardized diet containing only minor amounts of carotenoids, tocopherols, 
phylloquinone, and vitamin A.  On day 4, breakfast and dinner were consumed under supervision 
in the Iowa State University Nutrition and Wellness Research Center; the lunch and snacks were 
carried out.  The nutrient contents of the diet were analyzed by Nutritionist Pro nutrition analysis 
software (Axxya Systems, Stafford, TX).  The daily diet provided 2249 Kcals, 71.57 g protein, 
48.10 g fat, and 380.53 g carbohydrate.  The calculated carotenoid and fat-soluble vitamin 
contents of the daily diet were 11.23 μg β-carotene, 0.18 μg lutein (plus zeaxanthin), 0.05 β-
cryptoxanthin, 2.97 mg vitamin E, 15.44 μg vitamin K, 56.96 μg RAE vitamin A.  On day 5, 
subjects again reported to the Nutrition and Wellness Research Center.  A 10-mL blood sample 
was collected at baseline after an overnight fast.  The subjects consumed the test salad, and 
additional blood samples were collected at 2, 3.5, 5, 7 and 9.5 h after the test salad consumption.  
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Blood samples were transferred to 10-mL vacutainer tubes containing spray-dried K2 EDTA as 
anticoagulant (BD Vacutainer®, Becton, Dickinson, and Co).  Blood samples were immediately 
placed on ice and then centrifuged (700 × g, 4° C, 30 min) to separate plasma.  During these 
procedures, blood samples were protected from light.  After the 5-h blood sample collection, the 
subjects consumed a low-fat lunch that was also low in carotenoids, tocopherols, phylloquinone, 
and vitamin A.  On the basis of analysis with the Nutritionist Pro software, the morning snack 
and lunch were estimated to contain 0.32 g and 1.50 g fat, respectively.   
Triglyceride-rich lipoprotein (TRL) isolation  
Chylomicrons and large VLDL (VLDLA) were isolated from plasma by cumulative rate 
ultracentrifugation (25, 26).  To form the density gradient, salt solutions were prepared, 
including a 1.006 g/mL sodium chloride stock solution at pH 7.0, and 1.020 g/mL and 1.065 
g/mL potassium bromide (KBr) solutions prepared from the 1.006 g/mL sodium chloride stock 
solution.  The densities were confirmed by using a digital density meter (DMA-48; Anton-Paar 
USA, Ashland, VA).  Four milliliters of plasma were transferred to a centrifuge tube (Ultra Clear, 
Beckman Instruments, Inc, Spinco Division, Palo Alto, CA), and 0.14 g KBr/mL was added to 
adjust the density to 1.10 g/mL.  The prepared salt solutions were overlaid on the plasma in order 
of highest to lowest density: 1) 3 mL of 1.0065 g/mL density solution; 2) 3 mL of 1.020 g/mL 
density solution; 3) 2 mL of 1.006 g/mL density solution.  Because there were only six places in 
each Beckman SW 40i swinging bucket rotor, two ultracentrifuges (L8-70M, L-90K; Beckman 
Instruments Inc,) were used to centrifuge the plasma samples at 28,300 rpm (101,136 × g) for 43 
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min.  The chylomicron fraction was removed and the tube was refilled with 1.006 g/mL density 
solution.  The tube then underwent a second ultracentrifugation at 40,000 rpm (142,948 × g) for 
67 min.  The VLDLA fraction was then removed from the top of the centrifuge tube.  The 
chylomicron and VLDLA fractions were stored at -70°C until analyzed.  All procedures were 
performed under yellow light. 
 
ELISA assays of apolipoproteinB-48 and total apolipoprotein B 
The contents of apolipoprotein B-48 (apoB-48) and total apolipoprotein B (total apoB) in 
the chylomicron and VLDLA fractions were analyzed in triplicate by using commercial apoB-48 
(Human ApoB-48 ELISA kit, Shibayagi, Gunma, Japan) and total apoB (Total Human 
Apolipoprotein B ELISA assay, ALerCHECK, Inc. Portland, Maine) ELISA kits.  A 175-L 
aliquot of each chylomicron fraction and a 60-µL aliquot of each VLDLA fraction were analyzed 
by ELISA.  The remainder of each lipoprotein fraction was used for fat-soluble micronutrient 
analyses by HPLC with coulometric array electrochemical detection (HPLC-ECD).  The 
postprandial apoB-100 contents were obtained by subtracting the apoB-48 content from the total 
apoB content within each chylomicron and VLDLA sample.  The calculated apoB-100 contents 
were accurate because the apoB-48 ELISA has no cross reactivity with apoB-100 (27, 28), and 
the total apoB standard was calibrated against an international reference material (29). 
To evaluate the precision of the ELISA assays, we used a pooled plasma chylomicron and 
VLDLA fraction as a quality-control material.  Excess plasma collected during the study was 
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combined and used to isolate the chylomicron and VLDLA fractions.  The two fractions were 
then pooled, divided into multiple vials, and stored at -70°C.  Three replicates of the quality-
control material were routinely analyzed with each ELISA assay.  The mean (± SD) apoB-48 and 
total apoB contents in the quality-control material were 0.945 ± 0.0386 mg/L and 7.59 ± 0.264 
mg/L, respectively.  For the apoB-48 ELISA assay, the inter-assay CVs were 5.89% and 7.07% 
in the chylomicron and VLDLA sample sets, respectively.  For the total apoB ELISA assay, the 
inter-assay CVs were 7.16% and 6.36% in the chylomicron and VLDLA sample sets, 
respectively.   
HPLC-ECD analyses of carotenoids and fat-soluble vitamins in the plasma triacylglycerol-
rich lipoprotein (TRL) fractions 
The contents of the α- and β-carotene, lutein, lycopene, retinyl palmitate, phylloquinone, 
and α- and γ-tocopherol in the plasma triacylglycerol-rich lipoprotein fractions were analyzed by 
HPLC with coulometric array electrochemical detection (HPLC‒ECD).  The retinyl palmitate 
was analyzed as the major bioconversion product of the α- and -carotene consumed in the salad 
vegetables.  Each chylomicron/VLDLA sample (~2 mL) was deproteinated by addition of an 
equal volume of methanol (Fisher Scientific, Chicago, IL), followed by two extractions with 4 
mL of hexane (EMD Chemicals Inc. Gibbstown, NJ) containing 1 g/L butylated hydroxytoluene 
(BHT) (Fisher Scientific, Chicago, IL) to extract carotenoids, retinyl palmitate, phylloquinone, 
and tocopherols.  The combined hexane layers were dried by using a speed vacuum evaporator 
(Model SPD 131 DDA, Thermo Electron Corporation, Milford, MA) with a universal vacuum 
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system (UVS 800 DDA, Thermo Electron Corporation), and redissolved in 30 μL methanol 
(EMD Chemicals Inc. Gibbstown, NJ) and 30 μL methyl-tert-butyl ether (MTBE) (Sigma, St. 
Louis, MO).  A 25 μL aliquot was injected into the HPLC−ECD system.  The carotenoids, 
retinyl palmitate, phylloquinone, and tocopherols were separated on a C30 Carotenoid Column 
(Waters, Milford, MA) (30).  The mobile phase consisted of methanol (EMD Chemicals Inc., 
Gibbstown, NJ), MTBE (Sigma, St. Louis, MO) and aqueous ammonium acetate buffer (1.0 M, 
pH 4.6) (Sigma, St. Louis MO).  The proportions in mobile phases A and B of 
methanol:MTBE:ammonium acetate were 95:3:2 (by vol) and 25:73:2 (by vol), respectively.  
The following gradient was used: 0-1 min, 100% mobile phase A; 1-4 min, linear gradient to 
75% mobile phase B; 40-60 min, linear gradient to 100% mobile phase B.  The flow rate was 1.0 
mL/min.  An ESA CoulArray system (Chelmsford, MA) was operated by using CoulArray 
software (CoulArrayWin 2.0) and consisted of a 542 auto sampler set at 4°C, two 582 solvent 
delivery modules, CoulArray thermal organizer, and a 16-channel 5600A CoulArray detector.  
The applied detector cell potentials included the predominant response potential for carotenoids 
(450 mV), retinyl palmitate (750 mV), and tocopherols (300 mV).  For the simultaneous analysis 
of phylloquinone, reductive potentials (-800 mV) were applied to two detector channels, which 
were followed by two oxidative potentials (50 mV, 200 mV) on the subsequent two detector 
channels.  The 50 mV channel was used for the quantification of phylloquinone.  The detection 
limits for α-carotene, β-carotene, lycopene, lutein, phylloquinone, α-tocopherol, and γ-tocopherol 
were 0.010 g/L, 0.008 g/L, 0.046 g/L, 0.046 g/L, 0.027 g/L, 3.872 g/L, and 0.272 g/L, 
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respectively.  Trans-lycopene was the only lycopene isomer detected in the samples.  All sample 
preparations and extractions were performed under yellow light.  
HPLC-ECD analyses of carotenoids and fat-soluble vitamins in the salad vegetables 
Representative samples of the spinach, romaine lettuce, cherry tomatoes, and carrots from 
the test salads consumed during each of the 6 weeks of the study were stored at -70°C and 
analyzed in duplicate.  A modification of the method of Granado et al. (30) was used to extract 
and analyze carotenoids and tocopherols.  Frozen vegetable samples were thawed at room 
temperature before being processed in a food processor (Handy Chopper Plus HC3000; Black & 
Decker Corp, Towson, MD).  Briefly, carotenoids and tocopherols were extracted from 1 g of the 
vegetable homogenate with 12 mL of methanol containing 1 g/L BHT (Fisher Scientific, 
Chicago, IL) and 12 mL of tetrahydrofuran (THF) containing 1 g/L BHT (VWR, Boston, MA).  
An 0.5 mL aliquot of the methanol/THF extract was transferred to a screw-capped test tube and 
combined with 1.0 mL of 0.4 g/mL potassium hydroxide in methanol containing 0.1 M 
pyrogallol.  Each tube was flushed with argon and tightly capped before vortexing for 3 minutes.  
Two mL of ultrapure water were added and the tube was vortexed again for 30 sec.  Four mL of 
hexane/methylene chloride (5:1 by volume) was added and thoroughly mixed by vortexing for 
60 sec.  The sample was then centrifuged to separate the organic phase.  The organic phase was 
evaporated to dryness under vacuum.  The dried lipid extract was reconstituted with 1000 µL 
each of MTBE and methanol; a 25 µL aliquot was injected into the HPLC-ECD system.  All 
procedures were carried out under yellow light. 
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The procedure for extracting phylloquinone from the vegetables was a modification of a 
method of Koivu et al. (31).  Ten milliliters of 2-propanol were added to 1 g of homogenized 
vegetable sample.  After vortexing for 2 min, 5 mL of hexane were added and the sample was 
vortexed for 2 min.  The sample was then re-extracted using another 5 mL of hexane.  Five mL 
of ultrapure water were added followed by vigorous shaking.  Each sample was centrifuged for 5 
min at 700  g to separate the organic and water phases.  For romaine lettuce and spinach, the 
total volume of the hexane layer was recorded and a 1 mL aliquot was evaporated to dryness 
under vacuum.  Thus, the phylloquinone content in 1 g of lettuce or spinach was obtained by 
multiplying the content in 1 mL aliquot by the recorded total hexane volume.  Because of the low 
contents of phylloquinone in cherry tomatoes and carrots, the entire hexane layer (about 10 mL) 
was dried down under vacuum.  Each dried extract was reconstituted with 100 µL of MTBE and 
100 µL of methanol.  A 25 µL aliquot was injected into the HPLC-ECD system as described 
above. 
Statistical analyses 
Statistical analyses were performed by using SAS (version 9.2; SAS Institute Inc., Cary, 
NC).  The outcome variables were the 0–9.5 h area under the curve (AUC) values in the plasma 
chylomicron and VLDLA fractions for carotenoids, phylloquinone, retinyl palmitate, 
tocopherols, apoB-48, apoB-100 and total apoB.  The AUC values were calculated by the 
trapezoidal method using analyte content (expressed as the content in the chylomicron or 
VLDLA fractions isolated from 1 L plasma) as the y axis and time (h) as the x axis. 
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 ANCOVA was used to estimate the differences among the salad dressings in the AUC 
values of the fat-soluble micronutrients in the chylomicron and VLDLA fractions.  Visual 
inspection of the QQ plots of the residuals showed that log transformation of the AUC values 
eliminated unwanted curvature.  Therefore, the AUC values were log transformed to achieve 
normal distributions and analyzed by mixed model analysis of covariance (ANCOVA) using 
treatment and study period as fixed factors, subject as random factor, and the log of the baseline 
(0 h) analyte content [log(baseline)] as a covariate.  Log(baseline) was not a significant covariate 
for phylloquinone in chylomicron and VLDLA fractions.  Therefore, these outcome variables 
were analyzed by a mixed model analysis of variance (ANOVA) with AUC as the dependent 
variable and treatment and study period as fixed factors and subject as random factor.  The need 
for inclusion of treatment × study period and log(baseline) × treatment interaction terms was 
evaluated by using a custom model that included treatment and covariate as main effects and also 
these interaction terms.  The log(baseline) × treatment interaction was not significant for any of 
the analytes in either lipoprotein fraction (chylomicron or VLDLA) and thus this interaction term 
was excluded from the model.  There was a significant treatment × study period interaction for α-
carotene and β-carotene in VLDLA; thus this interaction term was retained as an additional fixed 
effect in the model for these outcome variables.  Posthoc multiple comparisons of least squares 
means were calculated by paired Student’s t-test using Tukey’s adjustment.  P values < 0.05 
were considered significant 
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The baseline (0 h) contents of carotenoids, retinyl palmitate, and tocopherols in the plasma 
chylomicron fraction were compared with those in the VLDLA fraction by using paired 
Student’s t-tests, which indicated significant baseline differences between the two fractions (P < 
0.001).  Due to these baseline imbalances, ANCOVA with baseline as covariate became 
problematic.  If log baseline values were used as a covariate, AUC values for each analyte in 
each of the two lipoprotein fractions were modeled as least squares means.  To adjust for 
differences in baseline analyte content across subjects, the least squares mean for the AUC 
values with log baseline as a covariate was calculated at the average baseline value for that 
analyte across all subjects.  However, this approach cannot adjust for the baseline differences 
between fractions.  Thus, the incremental AUC (iAUC) values were calculated and used to 
compare the postprandial responses for each carotenoid or fat-soluble vitamin in the plasma 
chylomicron versus VLDLA fractions.  The iAUC, which was defined as the area under the 
curve and above the baseline (0 h) value, was calculated by trapezoidal approximation.  If the 
postprandial content of a carotenoid or fat-soluble vitamin in a lipoprotein fraction at a specific 
time point was lower than the baseline fasting content, then that area below the baseline was 
included as a negative contribution toward the total calculated iAUC value.  The iAUC values in 
chylomicron and VLDLA fractions were compared by ANOVA with fraction and treatment as 
main factors and treatment × fraction interaction as random factor. 
Repeated-measures ANOVA was used to compare differences between the baseline (0 h) 
and postprandial contents of carotenoids, fat soluble vitamins, apoB-48, and apoB-100 in the 
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plasma lipoprotein fractions at the individual time points, 2 h, 3.5 h, 5 h, 7 h, and 9.5 h.  The 
repeated-measures ANOVA involved treatment and time as fixed factors and subject and subject 
× treatment as random factors.  The least squares means were compared by post-hoc t-tests by 
using Tukey’s adjustment.   
For the analytes that had significant postprandial increments, the times to reach maximal 
contents in the plasma lipoprotein fractions (tmax) were determined from visual examination of 
the data.  The tmax values of each analyte were compared between fractions by ANOVA with 
fraction, treatment and treatment × fraction interaction as fixed factors.  The least squares means 
were compared by post-hoc t-tests. 
The AUC values of apoB-48 and apoB-100 were compared between fractions by ANOVA 
with fraction and treatment as main factors and treatment × fraction as random factor.  The 
apoB-48 AUC value and apoB-100 AUC values were compared within each fraction by 
ANOVA with analyte and treatment as main factors and treatment × analyte as random factor.  P 
values < 0.05 were considered significant. 
RESULTS 
Carotenoid, phylloquinone, and tocopherol contents in the test salads 
The carotenoid, phylloquinone, and tocopherol contents in the test salads are presented in 
Table 1.  Across the 6 wk of the study, the mean contents (± SEs) of total carotenoids (α-
carotene, β-carotene, lutein, zeaxanthin, and lycopene), total tocopherols (α- and γ-tocopherols), 
and phylloquinone in the 247-g test salads were 30.660 ± 0.430 mg, 4.786 ± 0.202 mg, and 0.153 
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± 0.006 mg, respectively.  Thus, the contents of the bioactive components of interest in the raw 
vegetables were remarkably consistent.  The contents of α- and γ- tocopherol varied the most 
among all of the analytes in the salad vegetables.  Tocopherol contents in vegetables are 
dependent on growing conditions, e.g., growing season, sunlight intensity, and soil state (32-34).  
Postprandial changes in carotenoid and fat-soluble vitamin contents in the plasma 
chylomicron and VLDLA fractions 
There were no significant differences among the three salad dressings in the AUC values for 
the carotenoids or fat-soluble vitamins in the postprandial chylomicron or VLDLA fractions.  
The exception was a decrease in the AUC value of phylloquinone in the plasma chylomicron 
fraction when the salad dressing containing 3.2 g soybean oil and 0.8 g Solec® 8120 was 
consumed compared with the salad dressing containing 4 g soybean oil and 0 g Solec® 8120 (P 
< 0.02, Figure 1).  In contrast, the AUC values for phylloquinone in the VLDLA fraction were 
not different between the three salad dressings.  No significant differences were observed among 
the salad dressings in the AUC values for apoB-48 and apoB-100 in the postprandial 
chylomicron and VLDLA fractions.   
The iAUC values for each analyte between chylomicron and VLDLA fractions were 
compared.  In this statistical model, the effects of the salad dressing treatments were not 
significant for any of the analytes, including phylloquinone.  In contrast, in the previous 
statistical model (above), the chylomicron AUC value for phylloquinone was significantly lower 
when salad vegetables were consumed with the salad dressing containing 0.8 g Solec® 8120 
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compared with the salad dressing containing 0 g Solec® 8120.  This discrepancy reflects the 
overwhelming predominance of the appearance of phylloquinone in the VLDLA fraction, no 
matter which of the three salad dressings was consumed.  In other words, the postprandial 
distribution of phylloquinone between the chylomicron and VLDLA fractions was not affected 
by the addition of Solec® 8120 hydroxylated soy lecithin to salad dressing in the amounts used 
in the current study.  The iAUC values for α-carotene, β-carotene, lycopene, retinyl palmitate, 
and phylloquinone were substantially higher in the VLDLA than in the chylomicron fraction (P 
< 0.05, Table 2).  For example, β-Carotene, the major pro-vitamin A carotenoid in the salad 
vegetables, was primarily accumulated in the VLDLA fraction with mean (± SE) iAUC value of 
58.805 ± 8.608 nmol•h/L, whereas its mean (± SE) iAUC value in the chylomicron fraction was 
18.515 ± 2.055 nmol•h/L.  In addition, significant increases from baseline in the α-carotene, β-
carotene, lycopene, retinyl palmitate, and phylloquinone contents were observed in both the 
chylomicron and VLDLA fractions as early as 2 h after salad consumption (Figures 2 and 3).  
The mean (± SE) difference for tmax values of α-carotene, β-carotene, lycopene, retinyl 
palmitate, and phylloquinone in chylomicron fraction versus VLDLA fraction was -0.986 ± 
0.505, -0.792 ± 0.492, -1.361 ± 0.868, -2.153 ± 0.592, -1.000 ± 0.6931, respectively.  The tmax 
values of α-carotene, β-carotene, lycopene, retinyl palmitate, and phylloquinone were 
significantly lower in the chylomicron fraction than in the VLDLA fraction (P < 0.01), which 
means the maximal contents of these fat-soluble micronutrients were reached earlier in the 
chylomicron fraction compared with the VLDLA fraction (Figures 2 and 3). 
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In contrast with the other carotenoids, the mean iAUC value for lutein in the plasma 
VLDLA fraction was negative (-5.086 ± 2.918 nmol•h/L), even though there was a substantial 
amount of lutein in the salad vegetables (Table 1).  The VLDLA lutein contents at 2, 3.5, 5, 7, or 
9.5 h were not significantly different from the baseline (0 h) content (Figure 4). However, the 
mean iAUC value for lutein in the plasma chylomicron fraction was positive (2.608 ± 0.465 
nmol•h/L), and the plasma chylomicron lutein contents at 3.5 h and 5 h were significantly higher 
than the baseline (0 h) content (P < 0.05).  Thus, our data suggest that, unlike the other 
carotenoids,  newly absorbed lutein was primarily transported by the plasma chylomicron 
fraction with little or no accumulation in the VLDLA fraction.  
Under our study conditions, there were no postprandial increments in α- or γ-tocopherols in 
either the plasma chylomicron or VLDLA fractions.  The α- and γ-tocopherol contents in the 
chylomicron fraction did not significantly change until 7 h; then significant decreases from 
baseline were observed at both 7 h and 9.5 h (P < 0.01) (Figure 4).  In the VLDLA fraction, 
significant decreases in the α- and γ-tocopherol contents were observed as early as 3.5 h (P < 
0.01) (Figure 4).   
Overall, after consumption of the test salads with salad dressings containing only 4 g of 
total lipids, we observed notable differences among the fat-soluble micronutrients in their 
postprandial appearances in the plasma lipoprotein fractions.  
Postprandial changes in apolipoprotein B contents in the plasma chylomicron and VLDLA 
fractions 
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The plasma chylomicron and VLDLA fractions each contained both apoB-48 and apoB-
100, which is consistent with other studies (15, 29, 35-38).  The majority of the postprandial 
apoB-48 and apoB-100 was found in the VLDLA fraction (Figure 5).  The mean (± SE) absolute 
AUC values for apoB-48 in the chylomicron and VLDLA fractions were 0.535 ± 0.076 mg•h/L 
and 7.518 ± 0.918 mg•h/L, respectively.  The apoB-48 absolute AUC value in the VLDLA 
fraction was significantly higher than that in the chylomicron fraction (P < 0.0001).  Also, the 
mean (± SE) apoB-48 content in the VLDLA faction at baseline (0 h) (0.778 ± 0.115 mg/L) was 
about 10 times higher than the maximal postprandial mean (± SE) content of apoB-48 in the 
chylomicron fraction (0.080 ± 0.015 mg/L, at 2 h) (Figure 5).  Significant decreases in the apoB-
100 content from baseline were observed at 7 h in the chylomicron fraction (P < 0.01) and at 5 h, 
7 h, and 9.5 h in the VLDLA fraction (P < 0.01), and significant increases in the apoB-48 content 
from baseline were observed at 2 h and 3.5 h in the chylomicron fraction (P < 0.01) whereas no 
significant changes apoB-48 content were found in the VLDLA fraction (Figure 5).  One 
lipoprotein particle only contains one type of apoB, and apoB-48 and apoB-100 are reliable 
biomarkers for intestine- and liver-derived lipoproteins, respectly (18-20).  Thus, the changes in 
the apoB-48 and apoB-100 contents reflect the particle number changes in intestine- and liver-
derived lipoproteins, which means, in the postprandial state, the particle number of chylomicron-
sized enterogenous lipoproteins increased, and the particle number of chylomicron- and 
VLDLA-sized hepatogenous lipoproteins decreased.  The mean (± SE) absolute AUC values for 
apoB-100 in the chylomicron and VLDLA fractions were 1.110 ± 0.130 mg•h/L and 60.705 ± 
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5.748 mg•h/L, respectively.  As expected, the apoB-100 AUC value in the VLDLA fraction was 
significantly higher as compared with the chylomicron fraction (P < 0.0001).  Moreover, the 
apoB-100 absolute AUC value was substantially higher than the apoB-48 AUC value in both the 
plasma chylomicron and VLDLA fractions (P < 0.0001).  Thus, apoB-100 had greater 
postprandial appearance in both the chylomicron and VLDLA fractions than did apoB-48 after 
salad consumption.  
DISCUSSION 
In the current study, the apparent intestinal absorption of fat-soluble micronutrients from 
salad vegetables was measured based upon their postprandial appearances in the plasma 
chylomicron and VLDLA fractions.  Chylomicrons have long been regarded as the major 
lipoproteins that transport newly absorbed fat-soluble vitamins and other fat-soluble bioactive 
food components.  However, recently our group and others reported that measuring the 
appearance of retinyl esters in the VLDLA fraction is necessary to avoid underestimating total 
vitamin A absorption (13, 14).  Retinyl esters are formed in the enterocytes from provitamin A 
carotenoids, incorporated into chylomicrons, and subsequently cleared into liver hepatocytes in 
which they are hydrolyzed to retinol (39).  The liver secretes vitamin A back into the plasma 
primarily in the form of retinol bound to retinol-binding protein rather than in the form of retinyl 
esters with hepatogenous lipoproteins (40).  Thus, in the VLDLA fraction, the great increment in 
retinyl palmitate content in the VLDLA fraction most likely reflected the quantity of newly 
absorbed retinyl palmitate that was formed in the enterocytes from the α- and β-carotene 
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consumed in the salad vegetables.  Moreover, it has been shown that the appearance of β-
carotene in plasma after a single oral dose is biphasic (41, 42).  The early peak at 5-6 h post 
dosing represents the newly absorbed dietary β-carotene (43, 44), and the late and larger peak at 
24-48 h post dosing represents hepatic secretion of β-carotene in liver-derived lipoproteins (12).  
In the current study, we observed that the contents of α- and β-carotene, lycopene, retinyl 
palmitate, and phylloquinone peaked at 3.5 h and 5 h in the chylomicron and VLDLA fractions, 
respectively (Figure 2 and 3).  Thus, the increments in the carotenoid and phylloquinone 
contents in both lipoprotein fractions should reflect the quantities that were newly absorbed.  
However, their tmax values in the two fractions were not completely coincident; the later tmax 
within the VLDLA fraction than within the chylomicron fraction may reflect a precursor product 
relation.     
Based upon the AUC values, the postprandial appearance of α-carotene, β-carotene, 
lycopene, retinyl palmitate, and phylloquinone in the VLDLA fraction greatly exceeded their 
appearance in the chylomicron fraction (Table 2; Figures 2 and 3) (P < 0.05).  Thus, the 
majority of the newly absorbed fat-soluble micronutrients from the salad vegetables were 
contained within the large VLDL fraction in the context of this study in which the co-consumed 
salad dressing contained only 4 g of lipids.  In our earlier study, when a large β-carotene dose (25 
mg) was consumed with a 33-g fat load, Paetau et al. (12) reported that β-carotene was primarily 
accumulated within the plasma VLDLA fraction and there was a somewhat lower accumulation 
in chylomicrons.  In a subsequent study from our group, Hu et al. (11) showed that postprandial 
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accumulations of β-carotene and its major bioconversion product, retinyl palmitate, were of 
similar magnitude in the chylomicron and VLDLA fractions after a large (25 mg) dose of β-
carotene was consumed with 60 g of either beef tallow or sunflower oil.  These findings suggest 
that the distributions of β-carotene and retinyl palmitate in the chylomicron and VLDLA 
fractions may depend on the amount of co-consumed fat.  When the meal is rich in fat, newly 
absorbed β-carotene and retinyl palmitate are incorporated into chylomicron and VLDLA 
fractions in similar proportion.  When fat is limited, e.g. 4 g of total lipids in the current study, 
the VLDLA fraction contains the major transport particles for newly absorbed β-carotene and 
retinyl palmitate.  Under the current study conditions, newly absorbed α-carotene, lycopene, and 
phylloquinone were primarily accumulated in the VLDLA fraction instead of the chylomicron 
fraction.  This finding highlights the need for additional human studies regarding the effects of 
the fat content of the test meal on the distributions of these fat-soluble micronutrients in plasma 
lipoproteins, especially in chylomicrons and VLDLA particles.  Our study highlights the 
importance of measuring fat-soluble micronutrients in the postprandial VLDLA fraction to avoid 
underestimating carotenoid (-carotene, -carotene, and lycopene), retinyl palmitate, and 
phylloquinone absorption. 
In contrast to the other carotenoids, newly absorbed lutein from the salad vegetables was 
primarily incorporated into the plasma chylomicron fraction (Figure 4).  Paetau et al. (12) 
reported a rapid accumulation of canthaxanthin in chylomicron, VLDL and LDL fractions that 
began as early as 2 h post-dosing.  Canthaxanthin, which was used as a model xanthophyll 
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carotenoid, has plasma kinetics similar to those of lutein (45, 46).  The xanthophyll distribution 
difference in postprandial lipoproteins might be caused by differences in fat content.  In our 
current study, only 4 g of total lipids were consumed, whereas 33 g of fat were consumed in our 
previous study by Paetau et al.  These findings seem to suggest potential effects of fat content on 
the lipoprotein distribution of xanthophyll carotenoids, and the fat effects may be different from 
those on the distributions of other carotenoids, such as β-carotene.    
There were no postprandial increments in α- or γ-tocopherols in either the plasma 
chylomicron or VLDLA fractions when the salad was consumed with the test salad dressings 
containing a total of only 4 g of soybean lipids (Figure 4).  Reboul et al. (47) reported that α-
tocopherol is not secreted in chylomicrons when lipids are absent.  Similarly, Anwar et al. (48) 
showed that tocopherols were mostly incorporated into high density lipoproteins (HDL) in the 
absence of oleic acid.  In our previous study (49), subjects consumed test salads containing 
amounts of salad vegetables that matched those in the current study.  Significant increments in α- 
and γ-tocopherol contents in chylomicrons were observed only when the test salads were 
consumed with salad dressings containing 8 g or 32 g soybean oil.  Therefore, in the current 
study, the absence of newly absorbed α- and γ-tocopherols in chylomicron and VLDLA fractions 
may be caused by the limited amount of co-consumed soybean oil and a resulting incorporation 
into HDL.     
In humans, apoB-48 is secreted by the intestine and is a reliable marker of lipoprotein 
particles of intestinal origin (18-20).  ApoB-100 is primarily synthesized by the liver and is 
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regarded as a marker of lipoprotein particles of hepatic origin (17, 20).  Chylomicrons and 
VLDLA are usually referred to as apoB-48- and apoB-100-containing lipoproteins, respectively 
(16).  However, increasing evidence, including our current study, indicates that the chylomicron 
and VLDLA fractions each contain both apoB-48 and apoB-100 (15, 29, 35-38).  The evidence 
suggests that chylomicon and VLDLA fractions as isolated from human plasma each consist of 
both enterogenous and hepatogenous lipoprotein particles.  The chylomicrons and VLDLAs were 
isolated based upon their particle densities and sizes.  Thus, the presence of apoB-48 and apoB-
100 in both fractions shows that some postprandial apoB-48-containing lipoproteins have similar 
particle sizes with apoB-100-containing lipoproteins, as hypothesized by Nakano et al. (50).  The 
AUC value of apoB-48 was substantially higher in the VLDLA fraction than in the chylomicron 
fraction (P < 0.0001).  This finding implies that more enterogenous lipoprotein particles were 
contained in the VLDLA fraction, which can, at least partially, explain the greater postprandial 
appearance of α-carotene, β-carotene, lycopene, retinyl palmitate, and phylloquinone in the 
VLDLA fractions as compared with the chylomicron fraction.  Likewise, a higher AUC value for 
apoB-100 was observed in the VLDLA fraction than in the chylomicron fraction (P < 0.0001), 
which means that, as expected, more particles of hepatic origin were accumulated in the VLDLA 
fraction.  We observed higher baseline contents of carotenoids, retinyl palmitate, and tocopherols 
in the VLDLA fraction.  These higher baseline contents may be explained by the fact that plasma 
hepatogenous lipoprotein particles transport fat-soluble micronutrients, except retinyl palmitate, 
out of the liver (4).  
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The greater postprandial appearance of apoB-48 in the VLDLA fraction compared with the 
chylomicron fraction raises the question of the origin of the apoB-48-containing particles in 
VLDLA.  Two hypotheses may explain their origin: 1) they are the remnants of chylomicrons; 2) 
chylomicrons are not the sole precursor for VLDLA and a significant proportion of apoB-48-
containing VLDLA particles are directly secreted by the intestine.  The first hypothesis is based 
on the metabolism of fat-soluble micronutrients (51-54).  Fat-soluble micronutrients are taken up 
by the enterocytes, incorporated into chylomicrons, and transferred into the blood circulation via 
the lymphatic system (55).  In the bloodstream, the chylomicron triacylglycerols are hydrolyzed 
by the action of lipoprotein lipase, yielding chylomicron remnants (56, 57).  This hydrolysis 
process has been examined by labeling the triacylglycerol component of chylomicrons, and 
kinetic analyses showed it occurs within minutes (51, 52).  The second hypothesis was obtained 
from a lipoprotein kinetics study by Zheng et al. (15) in which apoB-48 and apoB-100 were 
labeled by stable isotopes.  The study indicated that the human intestine and liver are able to 
release various sizes of apoB-48 lipoproteins and apoB-100 lipoproteins, respectively, which 
range in size from chylomicrons- and VLDLs-, down to IDL-sized lipoproteins.  This finding 
implies that intestinal and hepatic lipoproteins do overlap in particle size, which has been 
supported by several recent studies (50, 58).  This hypothesis is also applicable to explain the 
origin of the apoB-100-containing particles in the chylomicron fraction in our study, i.e., they are 
secreted by the liver.  We also observed that the contents of α- and β-carotene, lycopene, retinyl 
palmitate, and phylloquinone peaked significantly earlier in the chylomicron fraction compared 
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with the VLDLA fraction (P < 0.01).  This finding can be explained by the first hypothesis, i.e. 
the tmax delay in the VLDLA fraction was attributed to the lipolysis of chylomicron 
triacylglycerols.  However, we only had 5 postprandial blood collection points.  Thus, it is 
possible that we missed the actual tmax for both the fractions, and they might overlap each other.  
Because a limited number of time points were applied in the current study, we cannot conclude 
with certainty which hypothesis is more applicable to our data.   
The apoB-100 AUC value was higher than the apoB-48 AUC value in both the chylomicron 
and VLDLA fractions (P < 0.0001).  Thus, the overall production of apoB-100 appears to be 
much higher than that of apoB-48, which has been shown by other studies (15, 36).  On the other 
hand, the high content of apoB-100 may be caused by the delayed lipolysis of apoB-100-
containing lipoproteins that must compete for lipoprotein lipase active sites with apoB-48-
containing lipoproteins (51-54, 59).  With the markedly higher apoB-100 content compared with 
apoB-48, we may conclude that the major postprandial lipoprotein is apoB-100-containing 
lipoprotein.  We also observed significant decreases of apoB-100 content from baseline in both 
the chylomicron and VLDLA fractions (P < 0.01), which is consistent with the finding in the 
apoB-48/100 kinetic study by Zheng et al. (15) that the postprandial apoB-100 mass decreased in 
the chylomicron and light VLDL fractions.  The reduction in apoB-100 content suggests that the 
number of hepatogenous lipoproteins decreases.  Recently, it was reported that the major 
increase in postprandial triacylglycerol was contained in apoB-100-containing lipoproteins 
instead of in apoB-48-containing lipoproteins (59).  Therefore, the decrease of apoB-100-
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containing particle number may be compensated by the increase of particle size by which apoB-
100-containing lipoproteins contain more fat-soluble micronutrients than apoB-48-containing 
lipoproteins.  In the current study, the significant increase of apoB-48 content was observed only 
in the chylomicron fraction, whereas Campos et al. (29) reported a increase in both chylomicron 
and VLDL fractions but a decrease in LDL fraction after a high-fat (104 g) breakfast 
consumption.  One explanation is that a highfat load stimulates the intestine to secrete more large 
VLDL-sized apoB-48 containing particles but less small LDL-sized apoB-48 containing particles 
in order to adjust the absorbed dietary fat (29).  The apoB-48/100 postprandial content depends 
on its production rate and clearance rate both of which were not clear in the current study due to 
no stable isotope tracers were applied (15, 60).       
In the current study, the addition of Solec® 8120, a commercial hydroxylated soy lecithin to 
salad dressing did not enhance the intestinal absorption of fat-soluble micronutrients from salad 
vegetables.  The AUC value for phylloquinone in the plasma chylomicron fraction was decreased 
when the salad dressing containing 3.2 g soybean oil and 0.8 g Solec® 8120 was consumed 
compared with the salad dressing containing 4 g soybean oil and 0 g Solec® 8120 (P < 0.02, 
Figure 1).  The decrease in the AUC value of phylloquinone may be attributed to the low 
postprandial contents of phylloquinone in the chylomicron fraction.  In the chylomicron fraction, 
the maximal postprandial content of phylloquinone (0.23 ± 0.09 nmol/L) was about 20 and 5 
times lower than those of β-Carotene (4.58 ± 1.27 nmol/L) and α-carotene (1.15 ± 0.36 nmol/L), 
respectively, when 3.2 g soybean oil and 0.8 g Solec® 8120 were consumed.  The bioavailability 
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of phylloquinone varies not only with the consumed fat content but also with the consumed fat 
composition (5, 7).  Jones et al. (61) reported that a polyunsaturated fatty acid-rich meal resulted 
in lower phylloquinone absorption compared with the other two meals that contained 2-fold 
lower polyunsaturated fatty acid.  But no systematic studies have addressed the effects of lecithin 
composition and/or content on the absorption of phylloquinone.  Moreover, in our study, 
phylloquinone was consumed from vegetables, whereas 20 μg of free 13C-labelled phylloquinone 
supplement were consumed with a fat-rich meal in the study by Jones et al (61).  Further 
investigations are thus needed to thoroughly assess the roles of lecithin and polyunsaturated fatty 
acid  food matrix interaction in phylloquinone absorption.  Lysophosphatidylcholine, a 
common component in commercial soy lecithins, was shown to enhance the bioavailability of β-
carotene, lutein, and α-tocopherol in rats, mice, and Caco-2 human intestinal cells (9, 62-64).  
The acyl chain length of phospholipids is also a critical factor influencing the bioavailability of 
fat-soluble micronutrients (65).  Yonekura and colleagues (65) reported that both medium-chain 
phosphatidylcholine and long-chain lysophosphatidylcholine increased β-carotene uptake.  In our 
study, we may have observed enhanced bioavailability of the fat-soluble micronutrients in the 
salad vegetables if homogeneous long-chain lysophosphatidylcholine had been added to the 
salad dressings.  However, pure lysophosphatidylcholine leads to lower quality salad dressings.  
Among the commercially-available lecithins, the hydroxylated soy lecithin in Solec® 8120 was 
determined to have the best product properties and taste profile.  It also improved acid stability.   
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In the current study, the apoB-48 content in both fractions was analyzed by apoB ELISA 
assay.  The assay uses a newly available apoB-48-specific monoclonal antibody that was raised 
against the apoB-48 C-terminal decapeptide (KLSQLQTYMI) and calibrated by using 
recombinant apoB-48 antigen (27).  The recovery of apoB-48 exceeds 90% (27).  The ELISA 
assay values are highly correlated with values obtained by gel scanning, which has often been 
used to quantify apoB-48 (28, 16).  However, compared with the ELISA assay values, the apoB-
48 values are underestimated by 50% with the gel scanning method (28).  In the current study, 
the intra- and inter-assay precision of the apoB-48 ELISA was evaluated by using a quality-
control material.  The inter-assay CVs and mean intra-assay CV were excellent (< 8%) in both 
the chylomicron and VLDLA samples.  The high-recovery and sensitivity of the apoB-48 ELISA 
confirm that it is a reliable method to quantify apoB-48 content in plasma samples. 
In conclusion, the addition of Solec® 8120 hydroxylated soy lecithin to salad dressing in 
the amounts used did not enhance the intestinal absorption of fat-soluble micronutrients from 
salad vegetables.  This study showed that the plasma VLDLA fraction contained the major 
transport particles for α-carotene, β-carotene, lycopene, retinyl palmitate, and phylloquinone 
over a 9.5-h period after consuming these bioactive components in salad vegetables with only 4 g 
of total lipid in salad dressing.  We showed that the plasma VLDLA fraction contains more 
enterogenous (apoB-48) and hepatogenous (apoB-100) lipoprotein particles as compared with 
the chylomicron fraction.  In this study, the fat-soluble micronutrients were consumed as they 
90 
 
 
naturally occur within salad vegetables.  Thus, our experimental conditions were similar to real 
diets and the outcomes have more realistic and physiological meanings. 
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TABLE 1 
Carotenoid, tocopherol, and phylloquinone contents in the vegetables in the test salads
1 
Component Weight α-Carotene β-Carotene Lutein Lycopene α-Tocopherol γ-Tocopherol Phylloquinone 
 
g mg 
Carrot, grated 66 
5.407 ± 
0.318
2
 
7.709 ± 
0.372 
0.211 ± 
0.022 
‒3 
0.424 ± 
0.019 
0.056 ± 
0.001 
0.002 ± 0.000 
Lettuce, romaine 48 ‒ 
1.394 ± 
0.139 
1.603 ± 
0.121 
‒ 
0.281 ± 
0.023 
0.277 ± 
0.021 
0.075 ± 0.006 
Spinach, leaf 48 ‒ 
2.172 ± 
0.078 
3.572 ± 
0.171 
‒ 
1.576 ± 
0.135 
0.148 ± 
0.008 
0.071 ± 0.005 
Tomato cherry 85 ‒ 
1.200 ± 
0.055 
0.187 ± 
0.014 
7.068 ± 
0.306 
1.479 ± 
0.065 
0.544 ± 
0.060 
0.004 ± 0.000 
Total 247 
5.407 ± 
0.318 
12.475 ± 
0.566 
5.574 ± 
0.292 
7.068 ± 
0.306 
3.760 ± 
0.128 
1.026 ± 
0.041 
0.152 ± 0.008 
1 
n = 6. A representative sample of each vegetable from each of the 6 weeks of the study was analyzed in duplicate. 
2
All values are means ± SEs. 
3 ‒ Not detected. 
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TABLE 2 
Incremental area under the response curve (iAUC) values for carotenoids, retinyl palmitate, and phylloquinone in plasma chylomicron 
and VLDLA fractions after consuming the test salads
1
 
 α-Carotene β-Carotene Lutein Lycopene Retinyl palmitate Phylloquinone 
          nmol · h/L 
Chylomicrons 4.507 ± 0.655
2
 18.515 ± 2.055 2.608 ± 0.465 0.913 ± 0.363 27.853 ± 3.982 1.482 ± 0.212 
VLDLA 22.162 ± 3.524
5
 58.805 ± 8.608
5
 -5.086 ± 2.918
3
 4.634 ± 1.147
4
 113.382 ± 14.784
5
 3.340 ± 0.504
4
 
1
n = 12 women; There were no significant treatment differences and data were combined across the three salad dressing treatments. 
The iAUC values in chylomicron and VLDLA fractions were compared by ANOVA with fraction and treatment as main factors 
and treatment × fraction interaction as a random factor. 
2
All values are means ± SEs. 
3,4,5
Significantly different from chylomicrons,
3
P < 0.05, 
4
P < 0.01, 
5
P < 0.001. 
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FIGURE 1.Mean (± SE) changes from baseline (fasting) in the content of phylloquinone in the plasma chylomicron fraction after 12 
women each consumed test salads with salad dressing containing 0 g, 0.2 g or 0.8 g Solec® 8120 hydroxylated soy lecithin.  A 
significant decrease (P < 0.02) in the chylomicron phylloquinone AUC values was observed when the salad dressing containing 0.8 g 
Solec® 8120 lecithin was consumed compared with the salad dressing containing 0 g Solec® 8120.   
  
1
0
0
 
 
FIGURE 2. Mean (± SE) changes from baseline in the contents of α-carotene, β-carotene, and lycopene in the plasma chylomicron 
(A) and VLDLA (B) fractions.  Repeated-measures ANOVA with Tukey’s adjustment was used to compare differences between the 
baseline and postprandial values of α- and β-carotene and lycopene at 2 h, 3.5 h, 5 h, 7 h, and 9.5 h, respectively.  Treatment and time 
were included in the model as fixed factors and subject and subject × treatment interactions as random factors.
*
P < 0.05, 
**
P < 0.01, 
***
P < 0.001. 
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FIGURE 3. Mean (± SE) changes from baseline in the contents of retinyl palmitate and phylloquinone in the plasma chylomicron (A) 
and VLDLA (B) fractions.  Repeated-measures ANOVA with Tukey’s adjustment was used to compare differences between the 
baseline and postprandial values of retinyl palmitate and phylloquinone at 2 h, 3.5 h, 5 h, 7 h, and 9.5 h, respectively.  Treatment and 
time were included in the model as fixed factors and subject and subject × treatment interactions as random factors.  
***
P < 0.001 
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FIGURE 4. Mean (± SE) changes from baseline in the contents of lutein, α-tocopherol and γ-tocopherol in the plasma chylomicron 
(A) and VLDLA (B) fractions.  Repeated-measures ANOVA with Tukey’s adjustment was used to compare differences between the 
baseline and postprandial values of lutein and tocopherols at 2 h, 3.5 h, 5 h, 7 h, and 9.5 h, respectively.  Treatment and time were 
included in the model as fixed factors and subject and subject × treatment interactions as random factors.
*
P < 0.05, 
**
P < 0.01, 
***
P < 
0.001 
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FIGURE 5. Mean (± SE) changes from baseline in the contents of apoB-48 and apoB-100 in the plasma chylomicron (A) and 
VLDLA (B) fractions.  Repeated-measures ANOVA with Tukey’s adjustment was used to compare differences between the baseline 
and postprandial values of lutein and tocopherols at 2 h, 3.5 h, 5 h, 7 h, and 9.5 h, respectively.  Treatment and time were included in 
the model as fixed factors and subject and subject × treatment interactions as random factors. 
**
P < 0.01  The AUC values of apoB-48 
and apoB-100 were compared between fractions by ANOVA analysis with fraction and treatment as fixed factors and treatment × 
fraction as random factor.  The apoB-48 AUC value and apoB-100 AUC value were compared within each fraction by ANOVA 
analysis with analyte and treatment as main factors and treatment × analyte as a random factor.  The apoB-48/apoB-100 AUC value in 
the VLDLA fraction was significantly higher than that in the chylomicron fraction (P < 0.0001).  The apoB-100 AUC value was 
substantially higher than the apoB-48 AUC value in both the plasma chylomicron and VLDLA fractions (P < 0.0001). 
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CHAPTER IV 
CONCLUSIONS AND PERSPECTIVES 
 
Salad consumption is a major contributor to vegetable consumption in the United States.  
Although it is associated with a greater likelihood of meeting the recommended intakes for 
various nutrients, the bioavailability of fat-soluble micronutrients, including carotenoids, 
tocopherols and phylloquinone, is low in raw vegetables, especially when co-consumed fat is 
limited.  To achieve high absorption of fat soluble micronutrients and meanwhile to avoid 
having excessively high fat intakes, we were looking for a lipid that is more efficient in 
increasing the bioavailability of fat-soluble micronutrients compared with triacylglycerol.  
Lecithin was a potential candidate, because it is a structural component of mixed micelles 
and an excellent emulsifier, and soybean lecithin was reported to enhance the absorption of 
diet triacylglycerol and curcumin, a lipophilic constituent of the spiceturmeric. 
Chylomicrons have long been regarded as the major transport particles for newly 
absorbed fat-soluble micronutrients.  Therefore, their postprandial appearance in 
chylomicrons has been utilized as an indicator of intestinal absorption.  However, in previous 
studies, we observed that postprandial appearances of β-carotene and retinyl palmitate in the 
plasma VLDLA fraction coincided with that in the chylomicron fraction in time and 
magnitude, which implied the importance of VLDLA as a vehicle for assessing intestinal 
absorption of β-carotene and its major bioconversion product, retinyl palmitate.  Few human 
studies have addressed the origin of VLDLA and the role of VLDLA in the transport of other 
newly absorbed fat-soluble micronutrients, such as α-carotene, lycopene, lutein, tocopherols, 
and phylloquinone.   
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We conducted a human study to investigate the effects of the lecithin/oil ratio in salad 
dressing on the absorption of fat-soluble micronutrients, as well as the roles of plasma 
chylomicrons and VLDLA in the transport of the absorbed fat-soluble micronutrients.  There 
were no significant differences among the salad dressings in the resulting AUC values of the 
fat-soluble micronutrients in the chylomicron and VLDLA fractions.  The exception was a 
decrease in the AUC value of phylloquinone in the chylomicron fraction when the salad 
dressing containing 0.8 mg hydroxylated soy lecithin (Solec® 8120) was consumed 
compared with the salad dressing containing 0 g Solec® 8120 (P < 0.02).  The AUC values 
for α-carotene, β-carotene, lycopene, retinyl palmitate, and phylloquinone were substantially 
higher in the VLDLA than in the chylomicron fraction (P < 0.05).  Both chylomicron and 
VLDLA fractions contained apoB-48 and apoB-100.  ApoB-48 and apoB-100 were mainly 
found in the VLDLA fraction (P < 0.0001).  The AUC value of apoB-100 was significantly 
higher than that of apoB-48 within each of the two fractions (P < 0.0001).   
We concluded that the hydroxylated soy lecithin in the amounts added to the salad 
dressing did not enhance the absorption of carotenoids, retinyl palmitate, phylloquinone, or 
tocopherols.  Over a 9.5-h period after consuming these bioactive components in salad 
vegetables with only 4 g of salad dressing, the majority of the newly absorbed α-carotene, β-
carotene, lycopene, retinyl palmitate, phylloquinone, as well as enterogenous (apoB-48) and 
hepatogenous (apoB-100) lipoprotein particles, were contained within large VLDL.  Thus 
this lipoprotein subfraction has a major role in the transport of newly absorbed carotenoids 
and fat-soluble vitamins.   
In this study, the fat-soluble micronutrients were consumed as they naturally occur 
within salad vegetables.  Thus, our experimental conditions were similar to real diets, and the 
106 
 
 
outcomes may reflect the actual distribution of fat-soluble micronutrients in postprandial 
triacylglyride-rich lipoproteins, i.e., the majority of newly absorbed fat-soluble 
micronutrients is contained in the VLDLA fraction instead of the chylomicron fraction.  This 
finding highlights the importance of measuring fat-soluble micronutrients in the postprandial 
VLDLA fraction to avoid underestimating carotenoid (-carotene, -carotene, and lycopene), 
retinyl palmitate, and phylloquinone bioavailibility.  Meanwhile, the findings of apoB-48 and 
apoB-100 in both the chylomicron and VLDLA fractions further support the hypothesis that 
apoB-48 and apoB-100 containing lipoproteins overlap in density.  Although the study 
design does not allow us to conclude with certainty the origin of VLDLA-sized apoB-48 
containing lipoproteins, our findings indicated the chylomicrons and VLDLA can not be 
simply regarded as enterogenous (apoB-48) and hepatogenous (apoB-100) lipoprotein 
particles, respectively.  In contrast, they are the mixtures of intestine- and liver-derived 
particles.  Thus, hepatic and intestinal lipoproteins should be separated by apoB isoform 
(apoB-48 or apoB-100) instead of particle size/density.   
Besides these major findings, we also observed some interesting phenomena that may 
inspire future studies and provide new insights regarding the mechanism of fat-soluble 
micronutrient absorption: 
1) Under the current study conditions, newly absorbed β-carotene and its major 
bioconversion product, retinyl palmitate, were primarily contained into the VLDLA fraction 
instead of the chylomicron fraction.  In contrast, our previous studies reported that the β-
carotene was primarily secreted into the VLDLA fraction followed by a slightly lower 
accumulation in chylomicron fraction when β-carotene dose (25 mg) was consumed with a 
meal containing 33 g of fat, and postprandial appearances of β-carotene and retinyl palmitate 
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in VLDLA fraction were of similar magnitude of those in chylomicron fraction after 
consumption of β-carotene (25 mg) with a fat-rich (60 g) meal.  These findings suggest the 
distributions of β-carotene and retinyl palmitate in chylomicron and VLDLA fractions may 
depend on the fat content in the co-consumed meal.  When the meal is rich in fat, newly 
absorbed β-carotene and retinyl palmitate are incorporated into chylomicron and VLDLA 
fractions with similar proportion.  When the fat is limited, VLDLAs become the major 
transport particles of newly absorbed β-carotene and retinyl palmitate.  This hypothesis 
requires further human studies in which fats with different amounts are consumed with 
identical meals and the distributions of fat-soluble micronutrients in postprandial lipoproteins 
are simultaneously investigated.  These studies can also provide an insight regarding the 
effect of fat content on the distributions of other fat-soluble micronutrients in the 
postprandial lipoproteins. 
2) In contrast to the other carotenoids, newly absorbed lutein was mainly incorporated 
into the chylomicron fraction after the salad consumption, whereas no increments were 
observed in the VLDLA fraction.  This finding highlights the difference of intestinal 
absorption between lutein and hydrocarbon carotenoids (e.g. α-carotene, β-carotene, 
lycopene).  Canthaxanthin has similar kinetics to those of lutein and has been shown to 
accumulate in chylomicron, VLDL and LDL fractions as early as 2 h post-dosing after the 
consumption of fat-rich (33 g) meal.  It seems to suggest potential effects of fat content on 
the lipoprotein distribution of lutein, and the effects may be different from those on the 
distributions of other carotenoid, such as β-carotene.  Moreover, ABCA1, a transmembrane 
transporter mediating nascent HDL secretion from the intestine, is associated with plasma 
lutein content and retinal pigment optical density.  When co-consumed lipids are limited, 
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tocopherols are mostly incorporated into nascent HDL through ABCA1.  Whether the 
analogous pathway exists in lutein intestinal absorption could be an interesting topic.  Further 
investigations into the lutein appearance in the whole spectrum of lipoproteins with various 
fat contents would be worthwhile as it may help to clarify the absorption and transport 
mechanism of lutein. 
3) Lutein had the strongest correlation with apoB-48 in the both chylomicron and 
VLDLA fractions compared with the other fat-soluble micronutrients (Table 3).  The 
correlation coefficients between the relative contents of apoB-48 and each fat-soluble 
micronutrient were calculated, where the relative content is defined as the value after 
baseline correction (posprandial content - baseline).  It is not clear that whether lutein is 
tightly associated with apoB-48 in molecular level.  But it has been reported that lutein is 
able to activate ERK1/2 (extracellular-signal-regulated kinases) that facilitate the formation 
of apoB-48 containing lipoproteins.  More in vitro and in vivo studies are needed to further 
explore the potential linkage between apoB-48 and lutein.  
4) We found both chylomicron and VLDLA fractions contain apoB-48 and apoB-100.  
Additional kinetics analysis is required to conclude which of the following hypotheses is 
more applicable to our data: 1) apoB-48 containing VLDLAs are the remnants of 
chylomicrons; 2) chylomicrons are not the sole precursor for VLDLAs, and a significant 
proportion of apoB-48 containing VLDLA are directly secreted by the intestine.  Two models 
can be designed: 1) Model 1 provides for the direct secretion of apoB-48 and apoB-100 into 
chylomicron and VLDLA fractions and allows apoB-48 and apoB-100 to leave the plasma at 
any compartment; 2) Model 2 used chylomicrons as the sole precursor for VLDLA.  
Simulation, Analysis, and Modeling Software (SAAM) can be used to find the best fit model.  
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TABLE 3. Correlation coefficients between the analytes and apoB-48 responses in 
chylomicron and VLDLA fractions
1, 2
 
 Correlation coefficient R 
In Chylomicrons In VLDLA 
Lutein 0.734 0.534 
α-Carotene 0.493 0.295 
β-Carotene 0.523 0.262 
Lycopene 0.589 0.240 
Retinyl palmitate 0.614 0.350 
α-Tocopherol 0.452 0.407 
γ-Tocopherol 0.464 0.468 
Phylloquinone 0.591 0.264 
1 
Data were combined across the 3 salad dressing treatments.   
2
All analytes were significantly correlated with apoB-48 in chylomicron and VLDLA 
fractions, P < 0.001.  
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APPENDIX  
 
TABLE 4. Hydroxylated soy lecithin (Solec® 8120) composition: 
Phospholipid  Weight-% Mol-% 
PC 15.14 24.81 
1-LPC /* /* 
2-LPC 3.74 9.17 
PI 8.19 12.37 
LPI 2.19 4.84 
PS-Na /* /* 
LPS /* /* 
SPH /* /* 
PE 0.66 1.15 
LPE /* /* 
APE 12.83 16.35 
PG 1.02 1.7 
DPG 0.69 1.27 
PA 5.55 10.23 
LPA 1.11 3.25 
Other 9.07 14.86 
Sum 60.19 100 
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TABLE 5. Salad dressing aqueous base formulation: 
Salad Dressing base formulation wt% 
Ultra pure reversed osmosis water 71.1458 
Sugar 10.0000 
Salt, refined 2.0000 
Keltrol 521 CP kelco 0.5000 
Waxy corn starch, E1422, Cluster S4R4   1.5000 
Spirit vinegar 12%   8.0000 
Citric acid monohydrate E330   0.1800 
EDTA dissolvine   0.0075 
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TABLE 6. Amount of lipid and the salad dressing (SD) base on the salad 
Treatment 
Hydroxylated 
soy lecithin (g) 
Soybean oil 
(g) SD base (g) Total (g) 
1 0.00 4.00 56.00 g 60.00 
2 0.20 3.80 56.00 g 60.00 
3 0.80 3.20 56.00 g 60.00 
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